export const drugInteractionData = [
  {
        "drug": "Acetaminophen",
        "interacting_drug": "Warfarin",
        "description": "The risk or severity of adverse effects can be increased when Acetaminophen is combined with Warfarin.",
        "extended_description": "Chronic oral acetaminophen use at a dose of 4,000 mg/day has been shown to cause an increase in INR in patients stabilized on sodium warfarin, increasing the risk of bleeding."
      },
      {
        "drug": "Aspirin",
        "interacting_drug": "Ibuprofen",
        "description": "Aspirin and Ibuprofen may increase the risk of gastrointestinal bleeding.",
        "extended_description": "Ibuprofen can interfere with the antiplatelet effects of aspirin, especially when taken together, increasing the risk of gastrointestinal ulceration and bleeding."
      },
      {
        "drug": "Simvastatin",
        "interacting_drug": "Amiodarone",
        "description": "Amiodarone can increase the serum concentration of Simvastatin, leading to an increased risk of muscle damage.",
        "extended_description": "Amiodarone inhibits the metabolism of Simvastatin via the CYP3A4 enzyme, which increases the risk of rhabdomyolysis (muscle breakdown)."
      },
      {
        "drug": "Metformin",
        "interacting_drug": "Furosemide",
        "description": "Furosemide may decrease the effectiveness of Metformin in controlling blood sugar levels.",
        "extended_description": "Chronic administration of Furosemide can lead to a decrease in the bioavailability of Metformin, thereby reducing its blood sugar-lowering effect."
      },
      {
        "drug": "Ciprofloxacin",
        "interacting_drug": "Tizanidine",
        "description": "Ciprofloxacin can increase the levels of Tizanidine, leading to excessive sedation and hypotension.",
        "extended_description": "Ciprofloxacin inhibits the CYP1A2 enzyme, which can increase the concentration of Tizanidine, causing severe hypotension, bradycardia, and excessive sedation."
      },
      {
        "drug": "Digoxin",
        "interacting_drug": "Verapamil",
        "description": "Verapamil increases the plasma levels of Digoxin, which may result in toxicity.",
        "extended_description": "Verapamil inhibits the renal and non-renal clearance of Digoxin, leading to elevated levels of the drug in the body, increasing the risk of toxicity."
      },
      {
        "drug": "Clopidogrel",
        "interacting_drug": "Omeprazole",
        "description": "Omeprazole may reduce the effectiveness of Clopidogrel in preventing blood clots.",
        "extended_description": "Omeprazole inhibits CYP2C19, an enzyme required to activate Clopidogrel, thus reducing the drug's ability to prevent blood clots."
      },
      {
        "drug": "Warfarin",
        "interacting_drug": "Ciprofloxacin",
        "description": "Ciprofloxacin may enhance the effects of Warfarin, increasing the risk of bleeding.",
        "extended_description": "Ciprofloxacin inhibits enzymes that metabolize Warfarin, leading to an increased INR and a higher risk of bleeding."
      },
      {
        "drug": "Lisinopril",
        "interacting_drug": "Spironolactone",
        "description": "The combination of Lisinopril and Spironolactone may increase the risk of hyperkalemia.",
        "extended_description": "Both Lisinopril (an ACE inhibitor) and Spironolactone (a potassium-sparing diuretic) can raise potassium levels, increasing the risk of dangerous hyperkalemia."
      },
      {
        "drug": "Levothyroxine",
        "interacting_drug": "Calcium Carbonate",
        "description": "Calcium Carbonate may reduce the absorption of Levothyroxine, reducing its effectiveness.",
        "extended_description": "Calcium supplements like Calcium Carbonate can bind to Levothyroxine in the gastrointestinal tract, reducing its absorption and making thyroid hormone replacement less effective."
      },
      {
        "drug": "Sertraline",
        "interacting_drug": "Tramadol",
        "description": "The combination of Sertraline and Tramadol may increase the risk of serotonin syndrome.",
        "extended_description": "Both Sertraline (an SSRI) and Tramadol (an opioid) can increase serotonin levels, which may result in a potentially life-threatening condition called serotonin syndrome."
      },
      {
        "drug": "Metoprolol",
        "interacting_drug": "Verapamil",
        "description": "Verapamil may enhance the effects of Metoprolol, increasing the risk of bradycardia and hypotension.",
        "extended_description": "Both Metoprolol (a beta-blocker) and Verapamil (a calcium channel blocker) slow down the heart rate, which can cause excessive bradycardia and hypotension when used together."
      },
      {
        "drug": "Phenytoin",
        "interacting_drug": "Doxycycline",
        "description": "Phenytoin may decrease the effectiveness of Doxycycline by increasing its metabolism.",
        "extended_description": "Phenytoin induces hepatic enzymes, which can lead to faster clearance of Doxycycline from the body, reducing its effectiveness in treating infections."
      },
      {
        "drug": "Fluoxetine",
        "interacting_drug": "Clozapine",
        "description": "Fluoxetine may increase Clozapine levels, increasing the risk of toxicity.",
        "extended_description": "Fluoxetine inhibits CYP2D6, leading to higher plasma concentrations of Clozapine, which can result in serious side effects like seizures and severe sedation."
      },
      {
        "drug": "Allopurinol",
        "interacting_drug": "Azathioprine",
        "description": "Allopurinol may increase the toxicity of Azathioprine.",
        "extended_description": "Allopurinol inhibits xanthine oxidase, an enzyme responsible for metabolizing Azathioprine, leading to elevated levels of Azathioprine and an increased risk of bone marrow suppression."
      },
      {
        "drug": "Lithium",
        "interacting_drug": "NSAIDs",
        "description": "NSAIDs may increase the serum concentration of Lithium, leading to toxicity.",
        "extended_description": "NSAIDs reduce renal clearance of Lithium, leading to an accumulation of Lithium in the blood and a higher risk of side effects such as tremors, confusion, and kidney damage."
      },
      {
        "drug": "Methotrexate",
        "interacting_drug": "Penicillin",
        "description": "Penicillin may increase the serum concentration of Methotrexate, leading to toxicity.",
        "extended_description": "Penicillin inhibits the renal clearance of Methotrexate, which can result in elevated drug levels, increasing the risk of bone marrow suppression and liver toxicity."
      },
      {
        "drug": "Atorvastatin",
        "interacting_drug": "Clarithromycin",
        "description": "Clarithromycin may increase the plasma concentration of Atorvastatin, increasing the risk of rhabdomyolysis.",
        "extended_description": "Clarithromycin inhibits CYP3A4, an enzyme responsible for metabolizing Atorvastatin, resulting in elevated levels of the statin and an increased risk of muscle toxicity."
      },
      {
        "drug": "Sildenafil",
        "interacting_drug": "Nitrates",
        "description": "Nitrates can significantly enhance the hypotensive effects of Sildenafil, leading to dangerous drops in blood pressure.",
        "extended_description": "The combination of Sildenafil (used for erectile dysfunction) and Nitrates (used for heart disease) can lead to profound hypotension, potentially resulting in fainting, stroke, or heart attack."
      },
      {
        "drug": "Citalopram",
        "interacting_drug": "Ondansetron",
        "description": "Citalopram and Ondansetron may increase the risk of QT prolongation and cardiac arrhythmias.",
        "extended_description": "Both Citalopram (an SSRI) and Ondansetron (a serotonin antagonist) can prolong the QT interval on an ECG, increasing the risk of potentially life-threatening heart arrhythmias."
      },
        {
          "drug": "Simvastatin",
          "interacting_drug": "Grapefruit juice",
          "description": "Grapefruit juice can increase the blood levels of Simvastatin, potentially leading to muscle damage.",
          "extended_description": "Grapefruit juice inhibits CYP3A4 enzyme in the intestine, which is responsible for metabolizing simvastatin. This interaction can lead to increased absorption of the drug, potentially causing myopathy or rhabdomyolysis."
        },
        {
          "drug": "Metformin",
          "interacting_drug": "Alcohol",
          "description": "Alcohol consumption while taking Metformin may increase the risk of lactic acidosis.",
          "extended_description": "Both metformin and alcohol can cause lactic acidosis. When combined, the risk is significantly increased, especially in patients with liver or kidney problems."
        },
        {
          "drug": "Ciprofloxacin",
          "interacting_drug": "Calcium supplements",
          "description": "Calcium supplements can reduce the absorption of Ciprofloxacin, making it less effective.",
          "extended_description": "Calcium ions can form complexes with ciprofloxacin in the gastrointestinal tract, reducing its absorption. It's recommended to take ciprofloxacin at least 2 hours before or 6 hours after calcium supplements."
        },
        {
          "drug": "Levothyroxine",
          "interacting_drug": "Iron supplements",
          "description": "Iron supplements can interfere with the absorption of Levothyroxine, potentially reducing its effectiveness.",
          "extended_description": "Iron can bind to levothyroxine in the gastrointestinal tract, forming insoluble complexes that are poorly absorbed. It's recommended to separate the administration of these drugs by at least 4 hours."
        },
        {
          "drug": "Fluoxetine",
          "interacting_drug": "Tramadol",
          "description": "The combination of Fluoxetine and Tramadol may increase the risk of serotonin syndrome.",
          "extended_description": "Both fluoxetine and tramadol increase serotonin levels in the brain. When used together, they can lead to excessive serotonin accumulation, potentially causing serotonin syndrome, a potentially life-threatening condition."
        },
        {
          "drug": "Warfarin",
          "interacting_drug": "Vitamin K",
          "description": "Vitamin K can decrease the effectiveness of Warfarin.",
          "extended_description": "Warfarin works by inhibiting vitamin K-dependent clotting factors. Consuming large amounts of vitamin K can counteract warfarin's effects, potentially leading to blood clot formation."
        },
        {
          "drug": "Lisinopril",
          "interacting_drug": "Potassium supplements",
          "description": "Combining Lisinopril with potassium supplements can lead to hyperkalemia.",
          "extended_description": "Lisinopril, an ACE inhibitor, reduces aldosterone production, which can increase potassium retention. When combined with potassium supplements, it may lead to dangerously high potassium levels."
        },
        {
          "drug": "Omeprazole",
          "interacting_drug": "Clopidogrel",
          "description": "Omeprazole can reduce the effectiveness of Clopidogrel.",
          "extended_description": "Omeprazole inhibits CYP2C19, an enzyme necessary for converting clopidogrel to its active form. This can reduce clopidogrel's antiplatelet effects, potentially increasing the risk of cardiovascular events."
        },
        {
          "drug": "Digoxin",
          "interacting_drug": "Amiodarone",
          "description": "Amiodarone can increase Digoxin levels, potentially leading to toxicity.",
          "extended_description": "Amiodarone inhibits P-glycoprotein, which is involved in digoxin elimination. This can lead to increased digoxin levels and potential toxicity, manifesting as nausea, vomiting, and cardiac arrhythmias."
        },
        {
          "drug": "Theophylline",
          "interacting_drug": "Ciprofloxacin",
          "description": "Ciprofloxacin can increase Theophylline levels, potentially causing toxicity.",
          "extended_description": "Ciprofloxacin inhibits CYP1A2, an enzyme responsible for metabolizing theophylline. This can lead to increased theophylline levels and potential toxicity, including nausea, seizures, and cardiac arrhythmias."
        },
        {
          "drug": "Sildenafil",
          "interacting_drug": "Nitrates",
          "description": "Combining Sildenafil with Nitrates can cause severe hypotension.",
          "extended_description": "Both sildenafil and nitrates cause vasodilation through the nitric oxide pathway. When used together, they can cause a dangerous drop in blood pressure, potentially leading to cardiovascular collapse."
        },
        {
          "drug": "Carbamazepine",
          "interacting_drug": "Erythromycin",
          "description": "Erythromycin can increase Carbamazepine levels, potentially causing toxicity.",
          "extended_description": "Erythromycin inhibits CYP3A4, which metabolizes carbamazepine. This can lead to increased carbamazepine levels and potential toxicity, including dizziness, ataxia, and diplopia."
        },
        {
          "drug": "Lithium",
          "interacting_drug": "NSAIDs",
          "description": "NSAIDs can increase Lithium levels, potentially leading to toxicity.",
          "extended_description": "NSAIDs can reduce renal lithium clearance, leading to increased lithium levels. This can result in lithium toxicity, manifesting as tremor, confusion, and potentially seizures or coma."
        },
        {
          "drug": "Methotrexate",
          "interacting_drug": "Probenecid",
          "description": "Probenecid can increase Methotrexate levels, potentially causing toxicity.",
          "extended_description": "Probenecid inhibits the renal tubular secretion of methotrexate, leading to increased methotrexate levels. This can result in methotrexate toxicity, including bone marrow suppression and liver damage."
        },
        {
          "drug": "Phenytoin",
          "interacting_drug": "Valproic acid",
          "description": "Valproic acid can increase free Phenytoin levels, potentially leading to toxicity.",
          "extended_description": "Valproic acid displaces phenytoin from protein binding sites and inhibits its metabolism, leading to increased free phenytoin levels. This can result in phenytoin toxicity, including ataxia and nystagmus."
        },
        {
          "drug": "Cyclosporine",
          "interacting_drug": "St. John's Wort",
          "description": "St. John's Wort can decrease Cyclosporine levels, potentially reducing its effectiveness.",
          "extended_description": "St. John's Wort induces CYP3A4, which metabolizes cyclosporine. This can lead to decreased cyclosporine levels and potential transplant rejection in organ transplant patients."
        },
        {
          "drug": "Allopurinol",
          "interacting_drug": "Azathioprine",
          "description": "Allopurinol can increase Azathioprine toxicity.",
          "extended_description": "Allopurinol inhibits xanthine oxidase, which is involved in azathioprine metabolism. This can lead to increased azathioprine levels and potential toxicity, including severe bone marrow suppression."
        },
        {
          "drug": "Rifampin",
          "interacting_drug": "Oral contraceptives",
          "description": "Rifampin can decrease the effectiveness of oral contraceptives.",
          "extended_description": "Rifampin induces CYP3A4, which metabolizes many oral contraceptives. This can lead to decreased contraceptive hormone levels and potential unintended pregnancy."
        },
        {
          "drug": "ACE inhibitors",
          "interacting_drug": "Spironolactone",
          "description": "Combining ACE inhibitors with Spironolactone can increase the risk of hyperkalemia.",
          "extended_description": "Both ACE inhibitors and spironolactone can increase potassium retention. When used together, they can lead to dangerously high potassium levels, potentially causing cardiac arrhythmias."
        },
        {
          "drug": "Clarithromycin",
          "interacting_drug": "Simvastatin",
          "description": "Clarithromycin can increase Simvastatin levels, potentially leading to muscle damage.",
          "extended_description": "Clarithromycin inhibits CYP3A4, which metabolizes simvastatin. This can lead to increased simvastatin levels and potential myopathy or rhabdomyolysis."
        },
            {
              "drug": "Artemether/Lumefantrine",
              "interacting_drug": "Efavirenz",
              "description": "Efavirenz can decrease the effectiveness of Artemether/Lumefantrine, potentially reducing antimalarial efficacy.",
              "extended_description": "Efavirenz induces CYP3A4, which metabolizes artemether and lumefantrine. This can lead to decreased blood levels of the antimalarial drugs, potentially reducing their effectiveness in treating malaria."
            },
            {
              "drug": "Tenofovir",
              "interacting_drug": "Non-steroidal anti-inflammatory drugs (NSAIDs)",
              "description": "NSAIDs may increase the risk of kidney injury when used with Tenofovir.",
              "extended_description": "Both tenofovir and NSAIDs can affect kidney function. When used together, especially in patients with pre-existing kidney issues, they may increase the risk of acute kidney injury or exacerbate chronic kidney disease."
            },
            {
              "drug": "Nevirapine",
              "interacting_drug": "Rifampicin",
              "description": "Rifampicin can significantly decrease Nevirapine levels, potentially leading to HIV treatment failure.",
              "extended_description": "Rifampicin is a potent inducer of CYP3A4 and CYP2B6, which metabolize nevirapine. This can lead to subtherapeutic levels of nevirapine, increasing the risk of HIV treatment failure and development of drug resistance."
            },
            {
              "drug": "Metformin",
              "interacting_drug": "Alcohol",
              "description": "Alcohol consumption while taking Metformin may increase the risk of lactic acidosis.",
              "extended_description": "Both metformin and alcohol can cause lactic acidosis. When combined, especially in patients with liver or kidney problems, the risk is significantly increased, which can be life-threatening."
            },
            {
              "drug": "Cotrimoxazole",
              "interacting_drug": "Methotrexate",
              "description": "Cotrimoxazole can increase Methotrexate toxicity.",
              "extended_description": "Cotrimoxazole inhibits the renal tubular secretion of methotrexate and can displace it from protein binding sites. This can lead to increased methotrexate levels and potential toxicity, including severe bone marrow suppression and liver damage."
            },
            {
              "drug": "Isoniazid",
              "interacting_drug": "Rifampicin",
              "description": "Rifampicin can decrease Isoniazid levels, but this combination is still used in tuberculosis treatment.",
              "extended_description": "Rifampicin induces the metabolism of isoniazid. However, this combination is still used as part of standard tuberculosis treatment regimens due to their synergistic effects against Mycobacterium tuberculosis."
            },
            {
              "drug": "Efavirenz",
              "interacting_drug": "Carbamazepine",
              "description": "Carbamazepine can significantly decrease Efavirenz levels, potentially leading to HIV treatment failure.",
              "extended_description": "Carbamazepine is a potent inducer of CYP3A4, which metabolizes efavirenz. This can lead to subtherapeutic levels of efavirenz, increasing the risk of HIV treatment failure and development of drug resistance."
            },
            {
              "drug": "Quinine",
              "interacting_drug": "Ritonavir",
              "description": "Ritonavir can increase Quinine levels, potentially leading to toxicity.",
              "extended_description": "Ritonavir inhibits CYP3A4, which metabolizes quinine. This can lead to increased quinine levels and potential toxicity, including cardiac arrhythmias, visual disturbances, and cinchonism."
            },
            {
              "drug": "Warfarin",
              "interacting_drug": "Aspirin",
              "description": "Aspirin can increase the risk of bleeding when used with Warfarin.",
              "extended_description": "Both warfarin and aspirin affect blood clotting. Aspirin inhibits platelet aggregation and can irritate the gastric mucosa. When used with warfarin, it significantly increases the risk of serious bleeding, including gastrointestinal bleeding."
            },
            {
              "drug": "Amoxicillin",
              "interacting_drug": "Oral contraceptives",
              "description": "Amoxicillin may reduce the effectiveness of oral contraceptives.",
              "extended_description": "Amoxicillin can alter gut flora, potentially affecting the enterohepatic recirculation of estrogens in oral contraceptives. This may lead to reduced contraceptive efficacy, although the clinical significance is debated."
            },
            {
              "drug": "Phenytoin",
              "interacting_drug": "Folic acid",
              "description": "Folic acid can decrease Phenytoin levels, potentially reducing its anticonvulsant effect.",
              "extended_description": "Folic acid can increase the metabolism of phenytoin, leading to decreased phenytoin levels. This can potentially reduce its effectiveness in controlling seizures. Conversely, phenytoin can also decrease folic acid absorption."
            },
            {
              "drug": "Fluconazole",
              "interacting_drug": "Nevirapine",
              "description": "Fluconazole can increase Nevirapine levels, potentially increasing the risk of liver toxicity.",
              "extended_description": "Fluconazole inhibits CYP3A4, which metabolizes nevirapine. This can lead to increased nevirapine levels and a higher risk of hepatotoxicity, especially in patients with higher CD4 counts or hepatitis coinfection."
            },
            {
              "drug": "Diazepam",
              "interacting_drug": "Alcohol",
              "description": "Alcohol can enhance the sedative effects of Diazepam, increasing the risk of respiratory depression.",
              "extended_description": "Both diazepam and alcohol are central nervous system depressants. When used together, they can cause excessive sedation, impaired cognitive function, and potentially dangerous respiratory depression."
            },
            {
              "drug": "Amlodipine",
              "interacting_drug": "Grapefruit juice",
              "description": "Grapefruit juice can increase Amlodipine levels, potentially leading to increased side effects.",
              "extended_description": "Grapefruit juice inhibits CYP3A4 in the intestine, which metabolizes amlodipine. This can lead to increased absorption and blood levels of amlodipine, potentially causing exaggerated hypotension and peripheral edema."
            },
            {
              "drug": "Metronidazole",
              "interacting_drug": "Alcohol",
              "description": "Alcohol consumption while taking Metronidazole can cause a disulfiram-like reaction.",
              "extended_description": "Metronidazole inhibits aldehyde dehydrogenase, which is necessary for alcohol metabolism. Consuming alcohol while on metronidazole can lead to accumulation of acetaldehyde, causing flushing, headache, nausea, vomiting, and tachycardia."
            },
                  {
                    "drug": "Acetaminophen",
                    "interacting_drug": "Warfarin",
                    "description": "The risk or severity of adverse effects can be increased when Acetaminophen is combined with Warfarin.",
                    "extended_description": "Chronic oral acetaminophen use at a dose of 4,000 mg/day has been shown to cause an increase in INR in patients stabilized on sodium warfarin, increasing the risk of bleeding."
                  },
                  {
                    "drug": "Aspirin",
                    "interacting_drug": "Ibuprofen",
                    "description": "Aspirin and Ibuprofen may increase the risk of gastrointestinal bleeding.",
                    "extended_description": "Ibuprofen can interfere with the antiplatelet effects of aspirin, especially when taken together, increasing the risk of gastrointestinal ulceration and bleeding."
                  },
                  {
                    "drug": "Simvastatin",
                    "interacting_drug": "Amiodarone",
                    "description": "Amiodarone can increase the serum concentration of Simvastatin, leading to an increased risk of muscle damage.",
                    "extended_description": "Amiodarone inhibits the metabolism of Simvastatin via the CYP3A4 enzyme, which increases the risk of rhabdomyolysis (muscle breakdown)."
                  },
                  {
                    "drug": "Metformin",
                    "interacting_drug": "Furosemide",
                    "description": "Furosemide may decrease the effectiveness of Metformin in controlling blood sugar levels.",
                    "extended_description": "Chronic administration of Furosemide can lead to a decrease in the bioavailability of Metformin, thereby reducing its blood sugar-lowering effect."
                  },
                  {
                    "drug": "Ciprofloxacin",
                    "interacting_drug": "Tizanidine",
                    "description": "Ciprofloxacin can increase the levels of Tizanidine, leading to excessive sedation and hypotension.",
                    "extended_description": "Ciprofloxacin inhibits the CYP1A2 enzyme, which can increase the concentration of Tizanidine, causing severe hypotension, bradycardia, and excessive sedation."
                  },
                  {
                    "drug": "Digoxin",
                    "interacting_drug": "Verapamil",
                    "description": "Verapamil increases the plasma levels of Digoxin, which may result in toxicity.",
                    "extended_description": "Verapamil inhibits the renal and non-renal clearance of Digoxin, leading to elevated levels of the drug in the body, increasing the risk of toxicity."
                  },
                  {
                    "drug": "Clopidogrel",
                    "interacting_drug": "Omeprazole",
                    "description": "Omeprazole may reduce the effectiveness of Clopidogrel in preventing blood clots.",
                    "extended_description": "Omeprazole inhibits CYP2C19, an enzyme required to activate Clopidogrel, thus reducing the drug's ability to prevent blood clots."
                  },
                  {
                    "drug": "Warfarin",
                    "interacting_drug": "Ciprofloxacin",
                    "description": "Ciprofloxacin may enhance the effects of Warfarin, increasing the risk of bleeding.",
                    "extended_description": "Ciprofloxacin inhibits enzymes that metabolize Warfarin, leading to an increased INR and a higher risk of bleeding."
                  },
                  {
                    "drug": "Lisinopril",
                    "interacting_drug": "Spironolactone",
                    "description": "The combination of Lisinopril and Spironolactone may increase the risk of hyperkalemia.",
                    "extended_description": "Both Lisinopril (an ACE inhibitor) and Spironolactone (a potassium-sparing diuretic) can raise potassium levels, increasing the risk of dangerous hyperkalemia."
                  },
                  {
                    "drug": "Levothyroxine",
                    "interacting_drug": "Calcium Carbonate",
                    "description": "Calcium Carbonate may reduce the absorption of Levothyroxine, reducing its effectiveness.",
                    "extended_description": "Calcium supplements like Calcium Carbonate can bind to Levothyroxine in the gastrointestinal tract, reducing its absorption and making thyroid hormone replacement less effective."
                  },
                  {
                    "drug": "Sertraline",
                    "interacting_drug": "Tramadol",
                    "description": "The combination of Sertraline and Tramadol may increase the risk of serotonin syndrome.",
                    "extended_description": "Both Sertraline (an SSRI) and Tramadol (an opioid) can increase serotonin levels, which may result in a potentially life-threatening condition called serotonin syndrome."
                  },
                  {
                    "drug": "Metoprolol",
                    "interacting_drug": "Verapamil",
                    "description": "Verapamil may enhance the effects of Metoprolol, increasing the risk of bradycardia and hypotension.",
                    "extended_description": "Both Metoprolol (a beta-blocker) and Verapamil (a calcium channel blocker) slow down the heart rate, which can cause excessive bradycardia and hypotension when used together."
                  },
                  {
                    "drug": "Phenytoin",
                    "interacting_drug": "Doxycycline",
                    "description": "Phenytoin may decrease the effectiveness of Doxycycline by increasing its metabolism.",
                    "extended_description": "Phenytoin induces hepatic enzymes, which can lead to faster clearance of Doxycycline from the body, reducing its effectiveness in treating infections."
                  },
                  {
                    "drug": "Fluoxetine",
                    "interacting_drug": "Clozapine",
                    "description": "Fluoxetine may increase Clozapine levels, increasing the risk of toxicity.",
                    "extended_description": "Fluoxetine inhibits CYP2D6, leading to higher plasma concentrations of Clozapine, which can result in serious side effects like seizures and severe sedation."
                  },
                  {
                    "drug": "Allopurinol",
                    "interacting_drug": "Azathioprine",
                    "description": "Allopurinol may increase the toxicity of Azathioprine.",
                    "extended_description": "Allopurinol inhibits xanthine oxidase, an enzyme responsible for metabolizing Azathioprine, leading to elevated levels of Azathioprine and an increased risk of bone marrow suppression."
                  },
                  {
                    "drug": "Lithium",
                    "interacting_drug": "NSAIDs",
                    "description": "NSAIDs may increase the serum concentration of Lithium, leading to toxicity.",
                    "extended_description": "NSAIDs reduce renal clearance of Lithium, leading to an accumulation of Lithium in the blood and a higher risk of side effects such as tremors, confusion, and kidney damage."
                  },
                  {
                    "drug": "Methotrexate",
                    "interacting_drug": "Penicillin",
                    "description": "Penicillin may increase the serum concentration of Methotrexate, leading to toxicity.",
                    "extended_description": "Penicillin inhibits the renal clearance of Methotrexate, which can result in elevated drug levels, increasing the risk of bone marrow suppression and liver toxicity."
                  },
                  {
                    "drug": "Atorvastatin",
                    "interacting_drug": "Clarithromycin",
                    "description": "Clarithromycin may increase the plasma concentration of Atorvastatin, increasing the risk of rhabdomyolysis.",
                    "extended_description": "Clarithromycin inhibits CYP3A4, an enzyme responsible for metabolizing Atorvastatin, resulting in elevated levels of the statin and an increased risk of muscle toxicity."
                  },
                  {
                    "drug": "Sildenafil",
                    "interacting_drug": "Nitrates",
                    "description": "Nitrates can significantly enhance the hypotensive effects of Sildenafil, leading to dangerous drops in blood pressure.",
                    "extended_description": "The combination of Sildenafil (used for erectile dysfunction) and Nitrates (used for heart disease) can lead to profound hypotension, potentially resulting in fainting, stroke, or heart attack."
                  },
                  {
                    "drug": "Citalopram",
                    "interacting_drug": "Ondansetron",
                    "description": "Citalopram and Ondansetron may increase the risk of QT prolongation and cardiac arrhythmias.",
                    "extended_description": "Both Citalopram (an SSRI) and Ondansetron (a serotonin antagonist) can prolong the QT interval on an ECG, increasing the risk of potentially life-threatening heart arrhythmias."
                  },
                  {
                    "drug": "Amoxicillin",
                    "interacting_drug": "Methotrexate",
                    "description": "Amoxicillin may increase the toxicity of Methotrexate by reducing its excretion.",
                    "extended_description": "Amoxicillin decreases the renal clearance of Methotrexate, which can lead to higher levels of the drug in the blood, increasing the risk of toxic side effects."
                  },
                  {
                    "drug": "Simvastatin",
                    "interacting_drug": "Grapefruit Juice",
                    "description": "Grapefruit juice may increase the concentration of Simvastatin in the blood, leading to an increased risk of muscle toxicity.",
                    "extended_description": "Grapefruit juice inhibits the CYP3A4 enzyme responsible for metabolizing Simvastatin, leading to higher levels of the drug and an increased risk of rhabdomyolysis."
                  },
                  {
                    "drug": "Metformin",
                    "interacting_drug": "Alcohol",
                    "description": "Alcohol may increase the risk of lactic acidosis in patients taking Metformin.",
                    "extended_description": "Heavy alcohol consumption can impair gluconeogenesis and may lead to lactic acidosis, a rare but serious side effect associated with Metformin."
                  },
                  {
                    "drug": "Duloxetine",
                    "interacting_drug": "NSAIDs",
                    "description": "The risk of gastrointestinal bleeding may be increased when Duloxetine is taken with NSAIDs.",
                    "extended_description": "Duloxetine can increase the risk of bleeding, and when combined with NSAIDs, this risk is further heightened due to the gastrointestinal effects of NSAIDs."
                  },
                  {
                    "drug": "Gabapentin",
                    "interacting_drug": "Morphine",
                    "description": "Gabapentin and Morphine may enhance central nervous system depression, leading to increased sedation.",
                    "extended_description": "The combination can lead to respiratory depression and increased sedation, requiring close monitoring and dosage adjustments."
                  },
                  {
                    "drug": "Propranolol",
                    "interacting_drug": "Rifampin",
                    "description": "Rifampin may decrease the effectiveness of Propranolol by increasing its metabolism.",
                    "extended_description": "Rifampin induces hepatic enzymes that metabolize Propranolol, leading to decreased plasma levels and potentially reducing its antihypertensive effects."
                  },
                  {
                    "drug": "Bupropion",
                    "interacting_drug": "Venlafaxine",
                    "description": "The combination may increase the risk of seizures, especially in susceptible individuals.",
                    "extended_description": "Both Bupropion and Venlafaxine can lower the seizure threshold, making the combination potentially dangerous for certain patients."
                  },
                  {
                    "drug": "Trazodone",
                    "interacting_drug": "Fluoxetine",
                    "description": "Fluoxetine may increase Trazodone levels, leading to enhanced sedation and increased risk of serotonin syndrome.",
                    "extended_description": "Fluoxetine inhibits CYP2D6, affecting the metabolism of Trazodone and increasing its concentration, which may enhance its sedative effects."
                  },
                  {
                    "drug": "Chlordiazepoxide",
                    "interacting_drug": "Phenobarbital",
                    "description": "The combination may enhance central nervous system depressant effects, increasing sedation.",
                    "extended_description": "Both Chlordiazepoxide (a benzodiazepine) and Phenobarbital (a barbiturate) are central nervous system depressants that may lead to significant sedation and respiratory depression when taken together."
                  },
                  {
                    "drug": "Nifedipine",
                    "interacting_drug": "Quinidine",
                    "description": "Quinidine may increase the levels of Nifedipine, leading to hypotension.",
                    "extended_description": "Quinidine inhibits the metabolism of Nifedipine, which can lead to increased drug levels and a risk of excessive blood pressure lowering."
                  },
                  {
                    "drug": "Lansoprazole",
                    "interacting_drug": "Ketoconazole",
                    "description": "Lansoprazole may reduce the absorption of Ketoconazole, decreasing its effectiveness.",
                    "extended_description": "Lansoprazole, a proton pump inhibitor, can raise gastric pH, which interferes with the absorption of Ketoconazole, an antifungal medication."
                  },
                  {
                    "drug": "Clonazepam",
                    "interacting_drug": "Alcohol",
                    "description": "The combination of Clonazepam and alcohol can enhance CNS depression, leading to respiratory depression.",
                    "extended_description": "Both substances can significantly impair motor function and respiratory drive, increasing the risk of severe sedation and overdose."
                  },
                  {
                    "drug": "Rizatriptan",
                    "interacting_drug": "Ergotamine",
                    "description": "The combination can increase the risk of serious cardiovascular effects.",
                    "extended_description": "Using Rizatriptan (a migraine medication) with Ergotamine (another migraine treatment) can lead to vasoconstriction and other cardiovascular complications."
                  },
                  {
                    "drug": "Sodium Bicarbonate",
                    "interacting_drug": "Digoxin",
                    "description": "Sodium Bicarbonate may increase the risk of Digoxin toxicity by decreasing its clearance.",
                    "extended_description": "Alkalinization of the urine can reduce renal excretion of Digoxin, leading to higher serum levels and a risk of toxicity."
                  },
                  {
                    "drug": "Insulin",
                    "interacting_drug": "Beta-Blockers",
                    "description": "Beta-Blockers may mask the symptoms of hypoglycemia in patients using Insulin.",
                    "extended_description": "Beta-Blockers can inhibit the sympathetic nervous system response to hypoglycemia, which may delay the recognition of low blood sugar levels."
                  },
                  {
                    "drug": "Valproate",
                    "interacting_drug": "Carbapenem Antibiotics",
                    "description": "Carbapenem antibiotics may reduce Valproate levels, increasing the risk of seizure.",
                    "extended_description": "Carbapenems can induce the metabolism of Valproate, leading to decreased drug levels and a potential increase in seizure frequency."
                  },
                  {
                    "drug": "Carvedilol",
                    "interacting_drug": "Cimetidine",
                    "description": "Cimetidine may increase Carvedilol levels, enhancing its hypotensive effects.",
                    "extended_description": "Cimetidine inhibits the hepatic metabolism of Carvedilol, leading to increased plasma concentrations and a higher risk of hypotension."
                  },
                  {
                    "drug": "Amlodipine",
                    "interacting_drug": "Simvastatin",
                    "description": "Amlodipine may increase the levels of Simvastatin, raising the risk of myopathy.",
                    "extended_description": "The combination may lead to increased concentrations of Simvastatin, resulting in an elevated risk of muscle-related side effects."
                  },
                  {
                    "drug": "Ipratropium",
                    "interacting_drug": "Tiotropium",
                    "description": "Using Ipratropium with Tiotropium may increase the risk of anticholinergic side effects.",
                    "extended_description": "Both Ipratropium and Tiotropium are anticholinergics, and using them together can lead to increased side effects like dry mouth and urinary retention."
                  },
                  {
                    "drug": "Isosorbide Mononitrate",
                    "interacting_drug": "Sildenafil",
                    "description": "The combination can cause severe hypotension and cardiovascular complications.",
                    "extended_description": "Both Isosorbide Mononitrate and Sildenafil lower blood pressure, which can lead to dangerous hypotension when used together."
                  },
                  {
                    "drug": "Tamsulosin",
                    "interacting_drug": "Cimetidine",
                    "description": "Cimetidine may increase the plasma concentration of Tamsulosin, leading to hypotension.",
                    "extended_description": "Cimetidine inhibits hepatic metabolism of Tamsulosin, resulting in increased levels and a risk of excessive blood pressure lowering."
                  },
                  {
                    "drug": "Enalapril",
                    "interacting_drug": "Potassium Supplements",
                    "description": "Potassium supplements may increase the risk of hyperkalemia when taken with Enalapril.",
                    "extended_description": "Enalapril can reduce potassium excretion, and when combined with potassium supplements, there is a higher risk of dangerously elevated potassium levels."
                  },
                  {
                    "drug": "Oral Contraceptives",
                    "interacting_drug": "Antibiotics",
                    "description": "Certain antibiotics may reduce the effectiveness of Oral Contraceptives.",
                    "extended_description": "Antibiotics like Rifampin can induce liver enzymes that metabolize contraceptive hormones, potentially leading to unintended pregnancy."
                  },
                  {
                    "drug": "Hydrochlorothiazide",
                    "interacting_drug": "Lithium",
                    "description": "Hydrochlorothiazide may increase the serum concentration of Lithium, leading to toxicity.",
                    "extended_description": "Thiazide diuretics like Hydrochlorothiazide can decrease renal clearance of Lithium, resulting in higher serum levels and increased risk of side effects."
                  },
                    {
                      "drug": "Artemether/Lumefantrine",
                      "interacting_drug": "Efavirenz",
                      "description": "Efavirenz can decrease the effectiveness of Artemether/Lumefantrine, potentially reducing antimalarial efficacy.",
                      "extended_description": "Efavirenz induces CYP3A4, which metabolizes artemether and lumefantrine. This can lead to decreased blood levels of the antimalarial drugs, potentially reducing their effectiveness in treating malaria."
                    },
                    {
                      "drug": "Tenofovir",
                      "interacting_drug": "Non-steroidal anti-inflammatory drugs (NSAIDs)",
                      "description": "NSAIDs may increase the risk of kidney injury when used with Tenofovir.",
                      "extended_description": "Both tenofovir and NSAIDs can affect kidney function. When used together, especially in patients with pre-existing kidney issues, they may increase the risk of acute kidney injury or exacerbate chronic kidney disease."
                    },
                    {
                      "drug": "Metronidazole",
                      "interacting_drug": "Alcohol",
                      "description": "Alcohol consumption while taking Metronidazole can cause a disulfiram-like reaction.",
                      "extended_description": "Metronidazole inhibits aldehyde dehydrogenase, which is necessary for alcohol metabolism. Consuming alcohol while on metronidazole can lead to accumulation of acetaldehyde, causing flushing, headache, nausea, vomiting, and tachycardia."
                    },
                    {
                      "drug": "Dolutegravir",
                      "interacting_drug": "Rifampicin",
                      "description": "Rifampicin can decrease Dolutegravir levels, potentially reducing its efficacy in HIV treatment.",
                      "extended_description": "Rifampicin is a potent inducer of UGT1A1 and CYP3A4, which metabolize dolutegravir. This can lead to reduced dolutegravir levels, necessitating dose adjustments in patients receiving both drugs for HIV and tuberculosis treatment."
                    },
                    {
                      "drug": "Atazanavir",
                      "interacting_drug": "Omeprazole",
                      "description": "Omeprazole can decrease Atazanavir absorption, potentially leading to HIV treatment failure.",
                      "extended_description": "Atazanavir requires an acidic environment for absorption. Omeprazole, by reducing stomach acid, can significantly decrease atazanavir absorption, potentially leading to subtherapeutic levels and treatment failure."
                    },
                    {
                      "drug": "Lopinavir/Ritonavir",
                      "interacting_drug": "Rifampicin",
                      "description": "Rifampicin can significantly decrease Lopinavir/Ritonavir levels, potentially leading to HIV treatment failure.",
                      "extended_description": "Rifampicin induces CYP3A4, which metabolizes lopinavir and ritonavir. This can lead to subtherapeutic levels of these antiretroviral drugs, increasing the risk of HIV treatment failure and drug resistance."
                    },
                    {
                      "drug": "Zidovudine",
                      "interacting_drug": "Ribavirin",
                      "description": "Ribavirin can increase the risk of anemia when used with Zidovudine.",
                      "extended_description": "Both zidovudine and ribavirin can cause anemia. When used together, especially in patients with HIV and hepatitis C co-infection, the risk of severe anemia is significantly increased."
                    },
                    {
                      "drug": "Lamivudine",
                      "interacting_drug": "Trimethoprim",
                      "description": "Trimethoprim can increase Lamivudine levels, potentially increasing the risk of side effects.",
                      "extended_description": "Trimethoprim inhibits the renal tubular secretion of lamivudine. This can lead to increased lamivudine levels, potentially increasing the risk of side effects such as headache, nausea, and fatigue."
                    },
                    {
                      "drug": "Efavirenz",
                      "interacting_drug": "Artemether/Lumefantrine",
                      "description": "Efavirenz can decrease the effectiveness of Artemether/Lumefantrine, potentially reducing antimalarial efficacy.",
                      "extended_description": "Efavirenz induces CYP3A4, which metabolizes artemether and lumefantrine. This can lead to decreased blood levels of the antimalarial drugs, potentially reducing their effectiveness in treating malaria."
                    },
                    {
                      "drug": "Isoniazid",
                      "interacting_drug": "Acetaminophen",
                      "description": "Isoniazid can increase the risk of acetaminophen-induced hepatotoxicity.",
                      "extended_description": "Isoniazid can induce CYP2E1, which is involved in the metabolism of acetaminophen to its toxic metabolite. This can increase the risk of liver damage, especially with high doses or chronic use of acetaminophen."
                    },
                    {
                      "drug": "Pyrazinamide",
                      "interacting_drug": "Allopurinol",
                      "description": "Allopurinol can decrease the effectiveness of Pyrazinamide in tuberculosis treatment.",
                      "extended_description": "Allopurinol inhibits xanthine oxidase, which is necessary for the conversion of pyrazinamide to its active form. This can reduce the effectiveness of pyrazinamide in treating tuberculosis."
                    },
                    {
                      "drug": "Ethambutol",
                      "interacting_drug": "Antacids",
                      "description": "Antacids can decrease the absorption of Ethambutol, potentially reducing its efficacy.",
                      "extended_description": "Antacids containing aluminum hydroxide can form complexes with ethambutol in the gastrointestinal tract, reducing its absorption. It's recommended to separate the administration of these drugs by at least 4 hours."
                    },
                    {
                      "drug": "Artemether/Lumefantrine",
                      "interacting_drug": "Grapefruit juice",
                      "description": "Grapefruit juice can increase Artemether/Lumefantrine levels, potentially increasing the risk of side effects.",
                      "extended_description": "Grapefruit juice inhibits CYP3A4, which metabolizes artemether and lumefantrine. This can lead to increased blood levels of these antimalarial drugs, potentially increasing the risk of side effects such as headache, dizziness, and palpitations."
                    },
                    {
                      "drug": "Quinine",
                      "interacting_drug": "Ciprofloxacin",
                      "description": "Ciprofloxacin can increase Quinine levels, potentially leading to toxicity.",
                      "extended_description": "Ciprofloxacin inhibits CYP3A4, which metabolizes quinine. This can lead to increased quinine levels and potential toxicity, including cardiac arrhythmias, visual disturbances, and cinchonism."
                    },
                    {
                      "drug": "Metformin",
                      "interacting_drug": "Furosemide",
                      "description": "Furosemide can increase the risk of lactic acidosis in patients taking Metformin.",
                      "extended_description": "Furosemide can cause dehydration and electrolyte imbalances, which may increase the risk of lactic acidosis in patients taking metformin, especially in those with impaired kidney function."
                    },
                    {
                      "drug": "Glibenclamide",
                      "interacting_drug": "Trimethoprim/Sulfamethoxazole",
                      "description": "Trimethoprim/Sulfamethoxazole can increase the hypoglycemic effect of Glibenclamide.",
                      "extended_description": "Trimethoprim/Sulfamethoxazole can displace glibenclamide from protein binding sites and inhibit its metabolism, leading to increased free drug levels. This can potentiate the hypoglycemic effect of glibenclamide, increasing the risk of low blood sugar."
                    },
                          {
                            "drug": "Amoxicillin",
                            "interacting_drug": "Methotrexate",
                            "description": "Amoxicillin may increase the toxicity of Methotrexate.",
                            "extended_description": "Amoxicillin can reduce the renal clearance of Methotrexate, potentially leading to increased serum levels and toxicity."
                          },
                          {
                            "drug": "Ciprofloxacin",
                            "interacting_drug": "Theophylline",
                            "description": "Ciprofloxacin may increase the serum concentration of Theophylline.",
                            "extended_description": "Ciprofloxacin can inhibit the metabolism of Theophylline, leading to elevated levels and increased risk of toxicity."
                          },
                          {
                            "drug": "Doxycycline",
                            "interacting_drug": "Warfarin",
                            "description": "Doxycycline may enhance the anticoagulant effect of Warfarin.",
                            "extended_description": "Doxycycline can interfere with the gut flora, affecting vitamin K production and potentially increasing the effects of Warfarin."
                          },
                          {
                            "drug": "Clindamycin",
                            "interacting_drug": "Erythromycin",
                            "description": "Clindamycin may antagonize the effects of Erythromycin.",
                            "extended_description": "The combination of Clindamycin and Erythromycin can lead to reduced efficacy of Erythromycin due to competitive inhibition."
                          },
                          {
                            "drug": "Azithromycin",
                            "interacting_drug": "Statins",
                            "description": "Azithromycin may increase the risk of statin-related myopathy.",
                            "extended_description": "Azithromycin can inhibit the metabolism of certain statins, increasing the risk of muscle-related side effects."
                          },
                          {
                            "drug": "Cephalexin",
                            "interacting_drug": "Probenecid",
                            "description": "Probenecid may decrease the renal excretion of Cephalexin.",
                            "extended_description": "The combination may lead to increased serum levels of Cephalexin and an enhanced risk of side effects."
                          },
                          {
                            "drug": "Levofloxacin",
                            "interacting_drug": "Corticosteroids",
                            "description": "Levofloxacin may increase the risk of tendon rupture when taken with corticosteroids.",
                            "extended_description": "The concurrent use of Levofloxacin and corticosteroids has been associated with an increased risk of tendon damage and rupture."
                          },
                          {
                            "drug": "Sulfamethoxazole/Trimethoprim",
                            "interacting_drug": "Warfarin",
                            "description": "Sulfamethoxazole/Trimethoprim may potentiate the effects of Warfarin.",
                            "extended_description": "This combination can enhance anticoagulation effects and increase the risk of bleeding due to potential interactions with Warfarin metabolism."
                          },
                          {
                            "drug": "Metronidazole",
                            "interacting_drug": "Alcohol",
                            "description": "Metronidazole may cause disulfiram-like reactions with alcohol.",
                            "extended_description": "The combination can lead to severe nausea, vomiting, and abdominal cramps when alcohol is consumed during or shortly after Metronidazole treatment."
                          },
                          {
                            "drug": "Nitrofurantoin",
                            "interacting_drug": "Antacids",
                            "description": "Antacids containing magnesium may reduce the absorption of Nitrofurantoin.",
                            "extended_description": "The presence of antacids can impair the absorption of Nitrofurantoin, potentially reducing its effectiveness."
                          },
                          {
                            "drug": "Vancomycin",
                            "interacting_drug": "Aminoglycosides",
                            "description": "Vancomycin may increase the risk of nephrotoxicity when used with Aminoglycosides.",
                            "extended_description": "The combination can lead to cumulative nephrotoxic effects, requiring monitoring of renal function during co-administration."
                          },
                          {
                            "drug": "Gentamicin",
                            "interacting_drug": "Loop Diuretics",
                            "description": "Gentamicin may increase the risk of ototoxicity when used with loop diuretics.",
                            "extended_description": "The concurrent use of Gentamicin and loop diuretics can lead to increased risk of hearing loss and balance issues."
                          },
                          {
                            "drug": "Ceftriaxone",
                            "interacting_drug": "Calcium Salts",
                            "description": "Ceftriaxone should not be administered with calcium salts due to risk of precipitation.",
                            "extended_description": "The combination can lead to serious complications like lung or kidney damage due to precipitate formation in the lungs or kidneys."
                          },
                          {
                            "drug": "Clarithromycin",
                            "interacting_drug": "Atorvastatin",
                            "description": "Clarithromycin may increase Atorvastatin levels, raising the risk of myopathy.",
                            "extended_description": "Clarithromycin inhibits CYP3A4, which metabolizes Atorvastatin, potentially leading to increased side effects associated with statins."
                          },
                          {
                            "drug": "Rifampin",
                            "interacting_drug": "Oral Contraceptives",
                            "description": "Rifampin may reduce the effectiveness of oral contraceptives.",
                            "extended_description": "Rifampin induces hepatic enzymes that metabolize contraceptive hormones, potentially leading to unintended pregnancy."
                          },
                          {
                            "drug": "Moxifloxacin",
                            "interacting_drug": "Antidiabetic medications",
                            "description": "Moxifloxacin may affect blood sugar levels when taken with antidiabetic medications.",
                            "extended_description": "Moxifloxacin can cause both hyperglycemia and hypoglycemia, necessitating close monitoring of blood glucose levels."
                          },
                          {
                            "drug": "Ampicillin",
                            "interacting_drug": "Allopurinol",
                            "description": "Ampicillin may increase the risk of skin rash when taken with Allopurinol.",
                            "extended_description": "The combination can lead to a higher incidence of skin reactions, which can be severe in some cases."
                          },
                          {
                            "drug": "Tetracycline",
                            "interacting_drug": "Antacids",
                            "description": "Antacids containing aluminum, calcium, or magnesium may reduce the absorption of Tetracycline.",
                            "extended_description": "The effectiveness of Tetracycline can be decreased due to impaired absorption when taken with these antacids."
                          },
                          {
                            "drug": "Cefazolin",
                            "interacting_drug": "Probenecid",
                            "description": "Probenecid may increase the serum concentration of Cefazolin.",
                            "extended_description": "By inhibiting the renal excretion of Cefazolin, Probenecid can lead to elevated drug levels and increased risk of side effects."
                          },
                          {
                            "drug": "Sulfamethoxazole",
                            "interacting_drug": "Cyclophosphamide",
                            "description": "Sulfamethoxazole may increase the risk of toxicity when taken with Cyclophosphamide.",
                            "extended_description": "The combination can elevate the risk of myelosuppression and other toxic effects associated with Cyclophosphamide."
                          },
                          {
                            "drug": "Tobramycin",
                            "interacting_drug": "Neuromuscular Blockers",
                            "description": "Tobramycin may enhance the effects of neuromuscular blockers.",
                            "extended_description": "The combination can lead to prolonged muscle paralysis and respiratory depression."
                          },
                          {
                            "drug": "Chloramphenicol",
                            "interacting_drug": "Warfarin",
                            "description": "Chloramphenicol may increase the anticoagulant effect of Warfarin.",
                            "extended_description": "Chloramphenicol can displace Warfarin from protein binding sites, leading to higher active drug levels and increased bleeding risk."
                          },
                          {
                            "drug": "Daptomycin",
                            "interacting_drug": "Statins",
                            "description": "Daptomycin may increase the risk of muscle toxicity when used with Statins.",
                            "extended_description": "Both Daptomycin and Statins have been associated with muscle-related side effects, requiring monitoring of muscle function."
                          },
                          {
                            "drug": "Quinupristin/Dalfopristin",
                            "interacting_drug": "Warfarin",
                            "description": "Quinupristin/Dalfopristin may increase Warfarin levels.",
                            "extended_description": "The combination may lead to an increased anticoagulant effect and necessitates close monitoring of INR levels."
                          },
                          {
                            "drug": "Fosfomycin",
                            "interacting_drug": "Antacids",
                            "description": "Antacids may reduce the absorption of Fosfomycin.",
                            "extended_description": "The presence of antacids can impair the effectiveness of Fosfomycin by reducing its absorption."
                          },
                          {
                            "drug": "Nafcillin",
                            "interacting_drug": "Probenecid",
                            "description": "Probenecid may increase the serum concentration of Nafcillin.",
                            "extended_description": "Probenecid inhibits renal excretion of Nafcillin, leading to increased levels and risk of toxicity."
                          },
                          {
                            "drug": "Penicillin",
                            "interacting_drug": "Methotrexate",
                            "description": "Penicillin may increase the toxicity of Methotrexate.",
                            "extended_description": "Penicillin can reduce renal clearance of Methotrexate, potentially leading to elevated serum levels and toxicity."
                          },
                          {
                            "drug": "Oxacillin",
                            "interacting_drug": "Corticosteroids",
                            "description": "Oxacillin may enhance the effects of corticosteroids.",
                            "extended_description": "The combination can lead to increased cortisol levels and a heightened risk of corticosteroid side effects."
                          },
                          {
                            "drug": "Cefepime",
                            "interacting_drug": "Vancomycin",
                            "description": "Cefepime may enhance the nephrotoxic effects of Vancomycin.",
                            "extended_description": "The combination can lead to increased risk of renal impairment, requiring close monitoring of kidney function."
                          },
                          {
                            "drug": "Rifaximin",
                            "interacting_drug": "Antiepileptic drugs",
                            "description": "Rifaximin may affect the absorption of antiepileptic drugs.",
                            "extended_description": "The presence of Rifaximin can potentially alter the effectiveness of antiepileptic medications, necessitating monitoring of seizure control."
                          },
                            {
                              "drug": "Artemether/Lumefantrine",
                              "interacting_drug": "Efavirenz",
                              "description": "Efavirenz can decrease the effectiveness of Artemether/Lumefantrine, potentially reducing antimalarial efficacy.",
                              "extended_description": "Efavirenz induces CYP3A4, which metabolizes artemether and lumefantrine. This can lead to decreased blood levels of the antimalarial drugs, potentially reducing their effectiveness in treating malaria."
                            },
                            {
                              "drug": "Tenofovir",
                              "interacting_drug": "Non-steroidal anti-inflammatory drugs (NSAIDs)",
                              "description": "NSAIDs may increase the risk of kidney injury when used with Tenofovir.",
                              "extended_description": "Both tenofovir and NSAIDs can affect kidney function. When used together, especially in patients with pre-existing kidney issues, they may increase the risk of acute kidney injury or exacerbate chronic kidney disease."
                            },
                            {
                              "drug": "Nevirapine",
                              "interacting_drug": "Rifampicin",
                              "description": "Rifampicin can significantly decrease Nevirapine levels, potentially leading to HIV treatment failure.",
                              "extended_description": "Rifampicin is a potent inducer of CYP3A4 and CYP2B6, which metabolize nevirapine. This can lead to subtherapeutic levels of nevirapine, increasing the risk of HIV treatment failure and development of drug resistance."
                            },
                            {
                              "drug": "Metformin",
                              "interacting_drug": "Alcohol",
                              "description": "Alcohol consumption while taking Metformin may increase the risk of lactic acidosis.",
                              "extended_description": "Both metformin and alcohol can cause lactic acidosis. When combined, especially in patients with liver or kidney problems, the risk is significantly increased, which can be life-threatening."
                            },
                            {
                              "drug": "Cotrimoxazole",
                              "interacting_drug": "Methotrexate",
                              "description": "Cotrimoxazole can increase Methotrexate toxicity.",
                              "extended_description": "Cotrimoxazole inhibits the renal tubular secretion of methotrexate and can displace it from protein binding sites. This can lead to increased methotrexate levels and potential toxicity, including severe bone marrow suppression and liver damage."
                            },
                            {
                              "drug": "Isoniazid",
                              "interacting_drug": "Rifampicin",
                              "description": "Rifampicin can decrease Isoniazid levels, but this combination is still used in tuberculosis treatment.",
                              "extended_description": "Rifampicin induces the metabolism of isoniazid. However, this combination is still used as part of standard tuberculosis treatment regimens due to their synergistic effects against Mycobacterium tuberculosis."
                            },
                            {
                              "drug": "Efavirenz",
                              "interacting_drug": "Carbamazepine",
                              "description": "Carbamazepine can significantly decrease Efavirenz levels, potentially leading to HIV treatment failure.",
                              "extended_description": "Carbamazepine is a potent inducer of CYP3A4, which metabolizes efavirenz. This can lead to subtherapeutic levels of efavirenz, increasing the risk of HIV treatment failure and development of drug resistance."
                            },
                            {
                              "drug": "Quinine",
                              "interacting_drug": "Ritonavir",
                              "description": "Ritonavir can increase Quinine levels, potentially leading to toxicity.",
                              "extended_description": "Ritonavir inhibits CYP3A4, which metabolizes quinine. This can lead to increased quinine levels and potential toxicity, including cardiac arrhythmias, visual disturbances, and cinchonism."
                            },
                            {
                              "drug": "Warfarin",
                              "interacting_drug": "Aspirin",
                              "description": "Aspirin can increase the risk of bleeding when used with Warfarin.",
                              "extended_description": "Both warfarin and aspirin affect blood clotting. Aspirin inhibits platelet aggregation and can irritate the gastric mucosa. When used with warfarin, it significantly increases the risk of serious bleeding, including gastrointestinal bleeding."
                            },
                            {
                              "drug": "Amoxicillin",
                              "interacting_drug": "Oral contraceptives",
                              "description": "Amoxicillin may reduce the effectiveness of oral contraceptives.",
                              "extended_description": "Amoxicillin can alter gut flora, potentially affecting the enterohepatic recirculation of estrogens in oral contraceptives. This may lead to reduced contraceptive efficacy, although the clinical significance is debated."
                            },
                            {
                              "drug": "Phenytoin",
                              "interacting_drug": "Folic acid",
                              "description": "Folic acid can decrease Phenytoin levels, potentially reducing its anticonvulsant effect.",
                              "extended_description": "Folic acid can increase the metabolism of phenytoin, leading to decreased phenytoin levels. This can potentially reduce its effectiveness in controlling seizures. Conversely, phenytoin can also decrease folic acid absorption."
                            },
                            {
                              "drug": "Fluconazole",
                              "interacting_drug": "Nevirapine",
                              "description": "Fluconazole can increase Nevirapine levels, potentially increasing the risk of liver toxicity.",
                              "extended_description": "Fluconazole inhibits CYP3A4, which metabolizes nevirapine. This can lead to increased nevirapine levels and a higher risk of hepatotoxicity, especially in patients with higher CD4 counts or hepatitis coinfection."
                            },
                            {
                              "drug": "Diazepam",
                              "interacting_drug": "Alcohol",
                              "description": "Alcohol can enhance the sedative effects of Diazepam, increasing the risk of respiratory depression.",
                              "extended_description": "Both diazepam and alcohol are central nervous system depressants. When used together, they can cause excessive sedation, impaired cognitive function, and potentially dangerous respiratory depression."
                            },
                            {
                              "drug": "Amlodipine",
                              "interacting_drug": "Grapefruit juice",
                              "description": "Grapefruit juice can increase Amlodipine levels, potentially leading to increased side effects.",
                              "extended_description": "Grapefruit juice inhibits CYP3A4 in the intestine, which metabolizes amlodipine. This can lead to increased absorption and blood levels of amlodipine, potentially causing exaggerated hypotension and peripheral edema."
                            },
                            {
                              "drug": "Metronidazole",
                              "interacting_drug": "Alcohol",
                              "description": "Alcohol consumption while taking Metronidazole can cause a disulfiram-like reaction.",
                              "extended_description": "Metronidazole inhibits aldehyde dehydrogenase, which is necessary for alcohol metabolism. Consuming alcohol while on metronidazole can lead to accumulation of acetaldehyde, causing flushing, headache, nausea, vomiting, and tachycardia."
                            },
                            {
                              "drug": "Dolutegravir",
                              "interacting_drug": "Rifampicin",
                              "description": "Rifampicin can decrease Dolutegravir levels, potentially reducing its efficacy in HIV treatment.",
                              "extended_description": "Rifampicin is a potent inducer of UGT1A1 and CYP3A4, which metabolize dolutegravir. This can lead to reduced dolutegravir levels, necessitating dose adjustments in patients receiving both drugs for HIV and tuberculosis treatment."
                            },
                            {
                              "drug": "Atazanavir",
                              "interacting_drug": "Omeprazole",
                              "description": "Omeprazole can decrease Atazanavir absorption, potentially leading to HIV treatment failure.",
                              "extended_description": "Atazanavir requires an acidic environment for absorption. Omeprazole, by reducing stomach acid, can significantly decrease atazanavir absorption, potentially leading to subtherapeutic levels and treatment failure."
                            },
                            {
                              "drug": "Lopinavir/Ritonavir",
                              "interacting_drug": "Rifampicin",
                              "description": "Rifampicin can significantly decrease Lopinavir/Ritonavir levels, potentially leading to HIV treatment failure.",
                              "extended_description": "Rifampicin induces CYP3A4, which metabolizes lopinavir and ritonavir. This can lead to subtherapeutic levels of these antiretroviral drugs, increasing the risk of HIV treatment failure and drug resistance."
                            },
                            {
                              "drug": "Zidovudine",
                              "interacting_drug": "Ribavirin",
                              "description": "Ribavirin can increase the risk of anemia when used with Zidovudine.",
                              "extended_description": "Both zidovudine and ribavirin can cause anemia. When used together, especially in patients with HIV and hepatitis C co-infection, the risk of severe anemia is significantly increased."
                            },
                            {
                              "drug": "Lamivudine",
                              "interacting_drug": "Trimethoprim",
                              "description": "Trimethoprim can increase Lamivudine levels, potentially increasing the risk of side effects.",
                              "extended_description": "Trimethoprim inhibits the renal tubular secretion of lamivudine. This can lead to increased lamivudine levels, potentially increasing the risk of side effects such as headache, nausea, and fatigue."
                            },
                            {
                              "drug": "Isoniazid",
                              "interacting_drug": "Acetaminophen",
                              "description": "Isoniazid can increase the risk of acetaminophen-induced hepatotoxicity.",
                              "extended_description": "Isoniazid can induce CYP2E1, which is involved in the metabolism of acetaminophen to its toxic metabolite. This can increase the risk of liver damage, especially with high doses or chronic use of acetaminophen."
                            },
                            {
                              "drug": "Pyrazinamide",
                              "interacting_drug": "Allopurinol",
                              "description": "Allopurinol can decrease the effectiveness of Pyrazinamide in tuberculosis treatment.",
                              "extended_description": "Allopurinol inhibits xanthine oxidase, which is necessary for the conversion of pyrazinamide to its active form. This can reduce the effectiveness of pyrazinamide in treating tuberculosis."
                            },
                            {
                              "drug": "Ethambutol",
                              "interacting_drug": "Antacids",
                              "description": "Antacids can decrease the absorption of Ethambutol, potentially reducing its efficacy.",
                              "extended_description": "Antacids containing aluminum hydroxide can form complexes with ethambutol in the gastrointestinal tract, reducing its absorption. It's recommended to separate the administration of these drugs by at least 4 hours."
                            },
                            {
                              "drug": "Artemether/Lumefantrine",
                              "interacting_drug": "Grapefruit juice",
                              "description": "Grapefruit juice can increase Artemether/Lumefantrine levels, potentially increasing the risk of side effects.",
                              "extended_description": "Grapefruit juice inhibits CYP3A4, which metabolizes artemether and lumefantrine. This can lead to increased blood levels of these antimalarial drugs, potentially increasing the risk of side effects such as headache, dizziness, and palpitations."
                            },
                            {
                              "drug": "Quinine",
                              "interacting_drug": "Ciprofloxacin",
                              "description": "Ciprofloxacin can increase Quinine levels, potentially leading to toxicity.",
                              "extended_description": "Ciprofloxacin inhibits CYP3A4, which metabolizes quinine. This can lead to increased quinine levels and potential toxicity, including cardiac arrhythmias, visual disturbances, and cinchonism."
                            },
                            {
                              "drug": "Metformin",
                              "interacting_drug": "Furosemide",
                              "description": "Furosemide can increase the risk of lactic acidosis in patients taking Metformin.",
                              "extended_description": "Furosemide can cause dehydration and electrolyte imbalances, which may increase the risk of lactic acidosis in patients taking metformin, especially in those with impaired kidney function."
                            },
                            {
                              "drug": "Glibenclamide",
                              "interacting_drug": "Trimethoprim/Sulfamethoxazole",
                              "description": "Trimethoprim/Sulfamethoxazole can increase the hypoglycemic effect of Glibenclamide.",
                              "extended_description": "Trimethoprim/Sulfamethoxazole can displace glibenclamide from protein binding sites and inhibit its metabolism, leading to increased free drug levels. This can potentiate the hypoglycemic effect of glibenclamide, increasing the risk of low blood sugar."
                            },
                            {
                              "drug": "Tenofovir",
                              "interacting_drug": "Ledipasvir/Sofosbuvir",
                              "description": "Ledipasvir/Sofosbuvir can increase Tenofovir levels, potentially increasing the risk of kidney toxicity.",
                              "extended_description": "Ledipasvir inhibits P-glycoprotein and BCRP, which are involved in tenofovir elimination. This can lead to increased tenofovir levels, potentially increasing the risk of kidney toxicity, especially in patients with pre-existing kidney disease."
                            },
                            {
                              "drug": "Efavirenz",
                              "interacting_drug": "Voriconazole",
                              "description": "Efavirenz can significantly decrease Voriconazole levels, potentially reducing its antifungal efficacy.",
                              "extended_description": "Efavirenz is a potent inducer of CYP2C19 and CYP3A4, which metabolize voriconazole. This can lead to subtherapeutic levels of voriconazole, potentially compromising its effectiveness in treating fungal infections."
                            },
                            {
                              "drug": "Dolutegravir",
                              "interacting_drug": "Iron supplements",
                              "description": "Iron supplements can decrease Dolutegravir absorption, potentially reducing its efficacy.",
                              "extended_description": "Iron supplements can form complexes with dolutegravir in the gastrointestinal tract, reducing its absorption. It's recommended to separate the administration of these drugs by at least 2 hours."
                            },
                            {
                              "drug": "Atazanavir",
                              "interacting_drug": "Tenofovir",
                              "description": "Tenofovir can decrease Atazanavir levels, potentially reducing its efficacy in HIV treatment.",
                              "extended_description": "Tenofovir can reduce atazanavir absorption and increase its renal clearance. This can lead to subtherapeutic levels of atazanavir, potentially compromising HIV treatment efficacy."
                            },
                            {
                              "drug": "Rifampicin",
                              "interacting_drug": "Clarithromycin",
                              "description": "Rifampicin can significantly decrease Clarithromycin levels, potentially reducing its antibacterial efficacy.",
                              "extended_description": "Rifampicin is a potent inducer of CYP3A4, which metabolizes clarithromycin. This can lead to subtherapeutic levels of clarithromycin, potentially compromising its effectiveness in treating bacterial infections."
                            },

                                {
                                  "drug": "Rifampicin",
                                  "interacting_drug": "Clarithromycin",
                                  "description": "Rifampicin can significantly decrease Clarithromycin levels, potentially reducing its antibacterial efficacy.",
                                  "extended_description": "Rifampicin is a potent inducer of CYP3A4, which metabolizes clarithromycin. This can lead to subtherapeutic levels of clarithromycin, potentially compromising its effectiveness in treating bacterial infections."
                                },
                                {
                                  "drug": "Efavirenz",
                                  "interacting_drug": "Amlodipine",
                                  "description": "Efavirenz can decrease Amlodipine levels, potentially reducing its antihypertensive effect.",
                                  "extended_description": "Efavirenz induces CYP3A4, which metabolizes amlodipine. This can lead to reduced amlodipine levels and potentially inadequate blood pressure control."
                                },
                                {
                                  "drug": "Artemether/Lumefantrine",
                                  "interacting_drug": "Lopinavir/Ritonavir",
                                  "description": "Lopinavir/Ritonavir can increase Artemether/Lumefantrine levels, potentially increasing the risk of side effects.",
                                  "extended_description": "Lopinavir/Ritonavir inhibits CYP3A4, which metabolizes artemether and lumefantrine. This can lead to increased levels of the antimalarial drugs, potentially causing more side effects such as headache and palpitations."
                                },
                                {
                                  "drug": "Tenofovir",
                                  "interacting_drug": "Gentamicin",
                                  "description": "Concurrent use of Tenofovir and Gentamicin may increase the risk of nephrotoxicity.",
                                  "extended_description": "Both tenofovir and gentamicin can cause kidney damage. When used together, especially in patients with pre-existing kidney issues, the risk of acute kidney injury is significantly increased."
                                },
                                {
                                  "drug": "Metformin",
                                  "interacting_drug": "Cimetidine",
                                  "description": "Cimetidine can increase Metformin levels, potentially increasing the risk of lactic acidosis.",
                                  "extended_description": "Cimetidine inhibits the renal tubular secretion of metformin, leading to increased metformin levels. This can potentially increase the risk of lactic acidosis, especially in patients with impaired kidney function."
                                },
                                {
                                  "drug": "Isoniazid",
                                  "interacting_drug": "Phenytoin",
                                  "description": "Isoniazid can increase Phenytoin levels, potentially leading to toxicity.",
                                  "extended_description": "Isoniazid inhibits CYP2C9 and CYP2C19, which metabolize phenytoin. This can lead to increased phenytoin levels and potential toxicity, including ataxia, nystagmus, and confusion."
                                },
                                {
                                  "drug": "Dolutegravir",
                                  "interacting_drug": "Metformin",
                                  "description": "Dolutegravir can increase Metformin levels, potentially increasing the risk of lactic acidosis.",
                                  "extended_description": "Dolutegravir inhibits the renal organic cation transporter 2 (OCT2), which is involved in metformin elimination. This can lead to increased metformin levels and a higher risk of lactic acidosis."
                                },
                                {
                                  "drug": "Nevirapine",
                                  "interacting_drug": "Ketoconazole",
                                  "description": "Nevirapine can significantly decrease Ketoconazole levels, potentially reducing its antifungal efficacy.",
                                  "extended_description": "Nevirapine induces CYP3A4, which metabolizes ketoconazole. This can lead to subtherapeutic levels of ketoconazole, potentially compromising its effectiveness in treating fungal infections."
                                },
                                {
                                  "drug": "Rifampicin",
                                  "interacting_drug": "Doxycycline",
                                  "description": "Rifampicin can decrease Doxycycline levels, potentially reducing its antibacterial efficacy.",
                                  "extended_description": "Rifampicin induces hepatic enzymes that metabolize doxycycline, leading to reduced doxycycline levels. This can potentially compromise its effectiveness in treating bacterial infections."
                                },
                                {
                                  "drug": "Efavirenz",
                                  "interacting_drug": "Simvastatin",
                                  "description": "Efavirenz can decrease Simvastatin levels, potentially reducing its lipid-lowering effect.",
                                  "extended_description": "Efavirenz induces CYP3A4, which metabolizes simvastatin. This can lead to reduced simvastatin levels and potentially inadequate cholesterol control."
                                },
                                {
                                  "drug": "Atazanavir",
                                  "interacting_drug": "Rifabutin",
                                  "description": "Atazanavir can increase Rifabutin levels, potentially increasing the risk of side effects.",
                                  "extended_description": "Atazanavir inhibits CYP3A4, which metabolizes rifabutin. This can lead to increased rifabutin levels and a higher risk of side effects such as uveitis and neutropenia."
                                },
                                {
                                  "drug": "Zidovudine",
                                  "interacting_drug": "Fluconazole",
                                  "description": "Fluconazole can increase Zidovudine levels, potentially increasing the risk of side effects.",
                                  "extended_description": "Fluconazole inhibits the glucuronidation of zidovudine, leading to increased zidovudine levels. This can potentially increase the risk of side effects such as anemia and neutropenia."
                                },
                                {
                                  "drug": "Tenofovir",
                                  "interacting_drug": "Acyclovir",
                                  "description": "Concurrent use of Tenofovir and Acyclovir may increase the risk of nephrotoxicity.",
                                  "extended_description": "Both tenofovir and acyclovir are eliminated by the kidneys. When used together, especially in patients with pre-existing kidney issues, the risk of acute kidney injury is increased."
                                },
                                {
                                  "drug": "Lopinavir/Ritonavir",
                                  "interacting_drug": "Phenytoin",
                                  "description": "Lopinavir/Ritonavir can decrease Phenytoin levels, potentially reducing its anticonvulsant effect.",
                                  "extended_description": "Lopinavir/Ritonavir induces the metabolism of phenytoin, leading to reduced phenytoin levels. This can potentially compromise seizure control in epileptic patients."
                                },
                                {
                                  "drug": "Artemether/Lumefantrine",
                                  "interacting_drug": "Metoclopramide",
                                  "description": "Metoclopramide can decrease the absorption of Artemether/Lumefantrine, potentially reducing its antimalarial efficacy.",
                                  "extended_description": "Metoclopramide increases gastric emptying, which can reduce the absorption of artemether and lumefantrine. This can potentially compromise the effectiveness of malaria treatment."
                                },
                                      {
                                        "drug": "Amlodipine",
                                        "interacting_drug": "Simvastatin",
                                        "description": "Amlodipine may increase the serum concentration of Simvastatin.",
                                        "extended_description": "The combination can enhance the risk of statin-related side effects, such as muscle pain and liver damage."
                                      },
                                      {
                                        "drug": "Metformin",
                                        "interacting_drug": "Rifampin",
                                        "description": "Rifampin may reduce the effectiveness of Metformin.",
                                        "extended_description": "Rifampin can induce hepatic enzymes, potentially decreasing Metformin levels and worsening glycemic control."
                                      },
                                      {
                                        "drug": "Lisinopril",
                                        "interacting_drug": "Potassium Supplements",
                                        "description": "Lisinopril may increase potassium levels when used with potassium supplements.",
                                        "extended_description": "The combination can lead to hyperkalemia, necessitating monitoring of serum potassium levels."
                                      },
                                      {
                                        "drug": "Hydrochlorothiazide",
                                        "interacting_drug": "Lithium",
                                        "description": "Hydrochlorothiazide may increase lithium levels.",
                                        "extended_description": "Thiazide diuretics can reduce renal clearance of lithium, leading to elevated levels and toxicity."
                                      },
                                      {
                                        "drug": "Warfarin",
                                        "interacting_drug": "Ciprofloxacin",
                                        "description": "Ciprofloxacin may enhance the anticoagulant effects of Warfarin.",
                                        "extended_description": "This combination can increase the risk of bleeding, requiring careful monitoring of INR."
                                      },
                                      {
                                        "drug": "Losartan",
                                        "interacting_drug": "NSAIDs",
                                        "description": "NSAIDs may reduce the effectiveness of Losartan.",
                                        "extended_description": "The combination can lead to decreased antihypertensive effects due to reduced renal blood flow."
                                      },
                                      {
                                        "drug": "Simvastatin",
                                        "interacting_drug": "Diltiazem",
                                        "description": "Diltiazem may increase the levels of Simvastatin.",
                                        "extended_description": "This combination can enhance the risk of statin-related side effects, including muscle pain and liver injury."
                                      },
                                      {
                                        "drug": "Furosemide",
                                        "interacting_drug": "Aminoglycosides",
                                        "description": "Furosemide may enhance the ototoxic effects of Aminoglycosides.",
                                        "extended_description": "This combination can increase the risk of hearing loss, requiring monitoring of auditory function."
                                      },
                                      {
                                        "drug": "Aspirin",
                                        "interacting_drug": "Anticoagulants",
                                        "description": "Aspirin may increase the risk of bleeding when taken with anticoagulants.",
                                        "extended_description": "The combination can lead to a higher incidence of gastrointestinal bleeding and requires careful monitoring."
                                      },
                                      {
                                        "drug": "Omeprazole",
                                        "interacting_drug": "Clopidogrel",
                                        "description": "Omeprazole may reduce the effectiveness of Clopidogrel.",
                                        "extended_description": "Omeprazole can inhibit CYP2C19, which is necessary for converting Clopidogrel into its active form, reducing its antiplatelet effect."
                                      },
                                      {
                                        "drug": "Gabapentin",
                                        "interacting_drug": "Opioids",
                                        "description": "Gabapentin may enhance the sedative effects of Opioids.",
                                        "extended_description": "The combination can lead to increased sedation and respiratory depression, requiring close monitoring."
                                      },
                                      {
                                        "drug": "Metoprolol",
                                        "interacting_drug": "Verapamil",
                                        "description": "Verapamil may increase the levels of Metoprolol.",
                                        "extended_description": "The combination can lead to bradycardia and hypotension due to additive effects on heart rate."
                                      },
                                      {
                                        "drug": "Candesartan",
                                        "interacting_drug": "Lithium",
                                        "description": "Candesartan may increase lithium levels.",
                                        "extended_description": "The combination can lead to lithium toxicity, requiring careful monitoring of serum lithium levels."
                                      },
                                      {
                                        "drug": "Atorvastatin",
                                        "interacting_drug": "Gemfibrozil",
                                        "description": "Gemfibrozil may significantly increase the levels of Atorvastatin.",
                                        "extended_description": "This combination can lead to a higher risk of statin-related side effects, such as myopathy and rhabdomyolysis."
                                      },
                                      {
                                        "drug": "Diphenhydramine",
                                        "interacting_drug": "Alcohol",
                                        "description": "Diphenhydramine may enhance the sedative effects of Alcohol.",
                                        "extended_description": "The combination can lead to increased drowsiness and impaired motor skills."
                                      },
                                      {
                                        "drug": "Levothyroxine",
                                        "interacting_drug": "Calcium Supplements",
                                        "description": "Calcium supplements may reduce the absorption of Levothyroxine.",
                                        "extended_description": "The presence of calcium can interfere with the absorption of Levothyroxine, leading to suboptimal thyroid hormone levels."
                                      },
                                      {
                                        "drug": "Sitagliptin",
                                        "interacting_drug": "Digoxin",
                                        "description": "Sitagliptin may increase Digoxin levels.",
                                        "extended_description": "The combination may require monitoring of Digoxin levels due to potential increases in serum concentration."
                                      },
                                      {
                                        "drug": "Ranitidine",
                                        "interacting_drug": "Ketoconazole",
                                        "description": "Ranitidine may reduce the absorption of Ketoconazole.",
                                        "extended_description": "The combination can lead to decreased effectiveness of Ketoconazole due to altered gastric pH."
                                      },
                                      {
                                        "drug": "Allopurinol",
                                        "interacting_drug": "Azathioprine",
                                        "description": "Allopurinol may increase the toxicity of Azathioprine.",
                                        "extended_description": "The combination can lead to elevated levels of Azathioprine, increasing the risk of myelosuppression."
                                      },
                                      {
                                        "drug": "Sertraline",
                                        "interacting_drug": "Tramadol",
                                        "description": "Sertraline may enhance the effects of Tramadol.",
                                        "extended_description": "The combination can increase the risk of serotonin syndrome, characterized by symptoms like confusion and agitation."
                                      },
                                      {
                                        "drug": "Citalopram",
                                        "interacting_drug": "St. John's Wort",
                                        "description": "St. John's Wort may reduce the effectiveness of Citalopram.",
                                        "extended_description": "This herbal supplement can induce CYP enzymes, decreasing the levels of Citalopram and leading to potential recurrence of depressive symptoms."
                                      },
                                      {
                                        "drug": "Dexamethasone",
                                        "interacting_drug": "CYP3A4 Inhibitors",
                                        "description": "CYP3A4 inhibitors may increase the levels of Dexamethasone.",
                                        "extended_description": "This combination can enhance the effects of Dexamethasone and increase the risk of side effects, including hyperglycemia."
                                      },
                                      {
                                        "drug": "Clonazepam",
                                        "interacting_drug": "Opioids",
                                        "description": "Clonazepam may enhance the respiratory depressant effects of Opioids.",
                                        "extended_description": "The combination can lead to profound sedation and respiratory depression, requiring careful monitoring."
                                      },
                                      {
                                        "drug": "Fluoxetine",
                                        "interacting_drug": "NSAIDs",
                                        "description": "Fluoxetine may increase the risk of gastrointestinal bleeding when taken with NSAIDs.",
                                        "extended_description": "The combination can lead to an increased risk of serious bleeding complications due to additive effects on platelet function."
                                      },
                                      {
                                        "drug": "Chloroquine",
                                        "interacting_drug": "Beta-Blockers",
                                        "description": "Chloroquine may increase the levels of Beta-Blockers.",
                                        "extended_description": "This combination can lead to increased blood pressure control and potential bradycardia."
                                      },
                                      {
                                        "drug": "Fexofenadine",
                                        "interacting_drug": "Ketoconazole",
                                        "description": "Ketoconazole may increase the levels of Fexofenadine.",
                                        "extended_description": "The combination can enhance the effects of Fexofenadine, potentially increasing side effects like drowsiness."
                                      },
                                      {
                                        "drug": "Metoclopramide",
                                        "interacting_drug": "Levodopa",
                                        "description": "Metoclopramide may reduce the effectiveness of Levodopa.",
                                        "extended_description": "The combination can interfere with the central dopaminergic effects of Levodopa, worsening Parkinson's symptoms."
                                      },
                                      {
                                        "drug": "Amiodarone",
                                        "interacting_drug": "Warfarin",
                                        "description": "Amiodarone may increase the effects of Warfarin.",
                                        "extended_description": "The combination can lead to increased anticoagulant effects, necessitating monitoring of INR levels."
                                      },
                                      {
                                        "drug": "Eplerenone",
                                        "interacting_drug": "ACE Inhibitors",
                                        "description": "ACE inhibitors may increase the risk of hyperkalemia when taken with Eplerenone.",
                                        "extended_description": "The combination can lead to elevated potassium levels, requiring regular monitoring."
                                      },
                                      {
                                        "drug": "Verapamil",
                                        "interacting_drug": "Digoxin",
                                        "description": "Verapamil may increase Digoxin levels.",
                                        "extended_description": "The combination can lead to toxicity, necessitating monitoring of serum Digoxin concentrations."
                                      },
                                      {
                                        "drug": "Nifedipine",
                                        "interacting_drug": "CYP3A4 Inhibitors",
                                        "description": "CYP3A4 inhibitors may increase the levels of Nifedipine.",
                                        "extended_description": "The combination can lead to enhanced blood pressure lowering effects and side effects."
                                      },
                                      {
                                        "drug": "Duloxetine",
                                        "interacting_drug": "Warfarin",
                                        "description": "Duloxetine may increase the effects of Warfarin.",
                                        "extended_description": "The combination can increase the risk of bleeding, requiring careful monitoring of INR."
                                      },
                                      {
                                        "drug": "Quetiapine",
                                        "interacting_drug": "CYP3A4 Inhibitors",
                                        "description": "CYP3A4 inhibitors may increase the levels of Quetiapine.",
                                        "extended_description": "The combination can lead to increased sedation and potential side effects."
                                      },
                                      {
                                        "drug": "Azithromycin",
                                        "interacting_drug": "Statins",
                                        "description": "Azithromycin may increase the levels of certain Statins.",
                                        "extended_description": "The combination can enhance the risk of statin-related side effects, including muscle pain."
                                      },
                                      {
                                        "drug": "Tramadol",
                                        "interacting_drug": "Serotonergic Drugs",
                                        "description": "Tramadol may enhance the effects of serotonergic drugs.",
                                        "extended_description": "This combination can increase the risk of serotonin syndrome."
                                      },
                                      {
                                        "drug": "Nitrofurantoin",
                                        "interacting_drug": "Antacids",
                                        "description": "Antacids may reduce the absorption of Nitrofurantoin.",
                                        "extended_description": "The combination can lead to suboptimal therapeutic levels of Nitrofurantoin."
                                      },
                                      {
                                        "drug": "Bupropion",
                                        "interacting_drug": "Monoamine Oxidase Inhibitors (MAOIs)",
                                        "description": "Bupropion may cause hypertensive crisis when taken with MAOIs.",
                                        "extended_description": "The combination can lead to severe hypertension, necessitating caution."
                                      },
                                      {
                                        "drug": "Isosorbide Mononitrate",
                                        "interacting_drug": "Sildenafil",
                                        "description": "Sildenafil may enhance the hypotensive effects of Isosorbide Mononitrate.",
                                        "extended_description": "The combination can lead to significant drops in blood pressure, requiring careful monitoring."
                                      },
                                      {
                                        "drug": "Acetaminophen",
                                        "interacting_drug": "Warfarin",
                                        "description": "Acetaminophen may enhance the anticoagulant effects of Warfarin.",
                                        "extended_description": "Chronic use can increase INR levels, leading to increased risk of bleeding."
                                      },
                                      {
                                        "drug": "Propranolol",
                                        "interacting_drug": "Rifampin",
                                        "description": "Rifampin may reduce the effectiveness of Propranolol.",
                                        "extended_description": "This combination can lead to increased heart rate and potential cardiovascular issues."
                                      },
                                      {
                                        "drug": "Lansoprazole",
                                        "interacting_drug": "Methotrexate",
                                        "description": "Lansoprazole may increase the levels of Methotrexate.",
                                        "extended_description": "This combination can increase the risk of Methotrexate toxicity."
                                      },
                                      {
                                        "drug": "Dexamethasone",
                                        "interacting_drug": "Aspirin",
                                        "description": "Aspirin may increase the risk of gastrointestinal bleeding when taken with Dexamethasone.",
                                        "extended_description": "The combination can lead to an increased risk of serious bleeding complications."
                                      },
                                      {
                                        "drug": "Fluconazole",
                                        "interacting_drug": "Rifampin",
                                        "description": "Rifampin may reduce the levels of Fluconazole.",
                                        "extended_description": "This combination can lead to suboptimal antifungal therapy."
                                      },
                                      {
                                        "drug": "Sodium Bicarbonate",
                                        "interacting_drug": "Quinidine",
                                        "description": "Sodium Bicarbonate may increase the levels of Quinidine.",
                                        "extended_description": "The combination can lead to increased risk of toxicity, necessitating monitoring of serum levels."
                                      },
                                      {
                                        "drug": "Albuterol",
                                        "interacting_drug": "Beta-Blockers",
                                        "description": "Beta-Blockers may reduce the effectiveness of Albuterol.",
                                        "extended_description": "The combination can lead to decreased bronchodilation, requiring caution."
                                      },
                                      {
                                        "drug": "Mirtazapine",
                                        "interacting_drug": "Serotonergic Drugs",
                                        "description": "Mirtazapine may enhance the effects of serotonergic drugs.",
                                        "extended_description": "This combination can increase the risk of serotonin syndrome."
                                      },
                                      {
                                        "drug": "Dapagliflozin",
                                        "interacting_drug": "Diuretics",
                                        "description": "Diuretics may increase the risk of dehydration when taken with Dapagliflozin.",
                                        "extended_description": "The combination can lead to hypotension and kidney injury."
                                      },
                                      {
                                        "drug": "Digoxin",
                                        "interacting_drug": "Verapamil",
                                        "description": "Verapamil may increase the levels of Digoxin.",
                                        "extended_description": "The combination can lead to Digoxin toxicity, requiring monitoring of serum levels."
                                      },
                                      {
                                        "drug": "Tamsulosin",
                                        "interacting_drug": "CYP3A4 Inhibitors",
                                        "description": "CYP3A4 inhibitors may increase the levels of Tamsulosin.",
                                        "extended_description": "The combination can lead to enhanced side effects, such as dizziness and hypotension."
                                      },
                                      {
                                        "drug": "Atenolol",
                                        "interacting_drug": "Calcium Channel Blockers",
                                        "description": "Calcium Channel Blockers may enhance the effects of Atenolol.",
                                        "extended_description": "This combination can lead to increased bradycardia and hypotension."
                                      },
                                      {
                                        "drug": "Salmeterol",
                                        "interacting_drug": "Beta-Blockers",
                                        "description": "Beta-Blockers may reduce the effectiveness of Salmeterol.",
                                        "extended_description": "The combination can lead to decreased bronchodilation."
                                      },
                                      {
                                        "drug": "Benazepril",
                                        "interacting_drug": "Potassium-Sparing Diuretics",
                                        "description": "Potassium-sparing diuretics may increase the risk of hyperkalemia when taken with Benazepril.",
                                        "extended_description": "The combination can lead to elevated potassium levels, requiring regular monitoring."
                                      },
                                      {
                                        "drug": "Ciprofloxacin",
                                        "interacting_drug": "Theophylline",
                                        "description": "Ciprofloxacin may increase the levels of Theophylline.",
                                        "extended_description": "This combination can lead to toxicity, necessitating monitoring of Theophylline levels."
                                      },
                                      {
                                        "drug": "Carbamazepine",
                                        "interacting_drug": "CYP3A4 Inhibitors",
                                        "description": "CYP3A4 inhibitors may increase the levels of Carbamazepine.",
                                        "extended_description": "The combination can enhance the effects of Carbamazepine, leading to potential toxicity."
                                      },
                                      {
                                        "drug": "Lamotrigine",
                                        "interacting_drug": "Valproate",
                                        "description": "Valproate may increase the levels of Lamotrigine.",
                                        "extended_description": "This combination can lead to increased risk of Lamotrigine toxicity."
                                      },
                                      {
                                        "drug": "Fenofibrate",
                                        "interacting_drug": "Statins",
                                        "description": "Fenofibrate may enhance the effects of Statins.",
                                        "extended_description": "The combination can lead to increased risk of muscle-related side effects."
                                      },
                                      {
                                        "drug": "Rivaroxaban",
                                        "interacting_drug": "CYP3A4 Inducers",
                                        "description": "CYP3A4 inducers may reduce the effectiveness of Rivaroxaban.",
                                        "extended_description": "The combination can lead to suboptimal anticoagulation."
                                      },
                                      {
                                        "drug": "Insulin",
                                        "interacting_drug": "Thiazolidinediones",
                                        "description": "Thiazolidinediones may enhance the effects of Insulin.",
                                        "extended_description": "The combination can increase the risk of hypoglycemia and weight gain."
                                      },
                                      {
                                        "drug": "Methotrexate",
                                        "interacting_drug": "Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)",
                                        "description": "NSAIDs may increase the toxicity of Methotrexate.",
                                        "extended_description": "The combination can lead to increased risk of renal toxicity."
                                      },
                                      {
                                        "drug": "Hydrochlorothiazide",
                                        "interacting_drug": "Lithium",
                                        "description": "Hydrochlorothiazide may increase the levels of Lithium.",
                                        "extended_description": "This combination can lead to Lithium toxicity, necessitating monitoring of serum levels."
                                      },
                                      {
                                        "drug": "Trazodone",
                                        "interacting_drug": "CYP3A4 Inhibitors",
                                        "description": "CYP3A4 inhibitors may increase the levels of Trazodone.",
                                        "extended_description": "The combination can lead to increased sedation and risk of overdose."
                                      },
                                      {
                                        "drug": "Clonazepam",
                                        "interacting_drug": "Opioids",
                                        "description": "Opioids may enhance the sedative effects of Clonazepam.",
                                        "extended_description": "The combination can increase the risk of respiratory depression."
                                      },
                                      {
                                        "drug": "Ranitidine",
                                        "interacting_drug": "Warfarin",
                                        "description": "Ranitidine may enhance the anticoagulant effects of Warfarin.",
                                        "extended_description": "The combination can increase the risk of bleeding, requiring careful monitoring."
                                      },
                                      {
                                        "drug": "Levothyroxine",
                                        "interacting_drug": "Calcium Supplements",
                                        "description": "Calcium supplements may interfere with the absorption of Levothyroxine.",
                                        "extended_description": "The combination can lead to suboptimal thyroid hormone levels."
                                      },
                                      {
                                        "drug": "Valproic Acid",
                                        "interacting_drug": "Carbapenems",
                                        "description": "Carbapenems may reduce the levels of Valproic Acid.",
                                        "extended_description": "This combination can lead to loss of seizure control."
                                      },
                                      {
                                        "drug": "Diltiazem",
                                        "interacting_drug": "Beta-Blockers",
                                        "description": "Beta-Blockers may enhance the effects of Diltiazem.",
                                        "extended_description": "The combination can lead to increased bradycardia and hypotension."
                                      },
                                      {
                                        "drug": "Prednisone",
                                        "interacting_drug": "Aspirin",
                                        "description": "Aspirin may increase the risk of gastrointestinal bleeding when taken with Prednisone.",
                                        "extended_description": "The combination can lead to serious bleeding complications."
                                      },
                                      {
                                        "drug": "Clopidogrel",
                                        "interacting_drug": "Proton Pump Inhibitors",
                                        "description": "Proton Pump Inhibitors may reduce the effectiveness of Clopidogrel.",
                                        "extended_description": "This combination can lead to suboptimal antiplatelet effects."
                                      },
                                      {
                                        "drug": "Phenobarbital",
                                        "interacting_drug": "Warfarin",
                                        "description": "Phenobarbital may reduce the anticoagulant effects of Warfarin.",
                                        "extended_description": "This combination can lead to increased risk of thrombosis."
                                      },
                                      {
                                        "drug": "Tetracycline",
                                        "interacting_drug": "Calcium Supplements",
                                        "description": "Calcium supplements may reduce the absorption of Tetracycline.",
                                        "extended_description": "This combination can lead to suboptimal antibiotic levels."
                                      },
                                      {
                                        "drug": "Amlodipine",
                                        "interacting_drug": "Simvastatin",
                                        "description": "Simvastatin may enhance the effects of Amlodipine.",
                                        "extended_description": "The combination can lead to increased risk of side effects."
                                      },
                                      {
                                        "drug": "Sildenafil",
                                        "interacting_drug": "Nitrates",
                                        "description": "Nitrates may enhance the hypotensive effects of Sildenafil.",
                                        "extended_description": "The combination can lead to significant drops in blood pressure."
                                      },
                                      {
                                        "drug": "Gabapentin",
                                        "interacting_drug": "Opioids",
                                        "description": "Opioids may enhance the sedative effects of Gabapentin.",
                                        "extended_description": "This combination can increase the risk of respiratory depression."
                                      },
                                      {
                                        "drug": "Omeprazole",
                                        "interacting_drug": "Clopidogrel",
                                        "description": "Omeprazole may reduce the effectiveness of Clopidogrel.",
                                        "extended_description": "The combination can lead to increased risk of cardiovascular events."
                                      },
                                      {
                                        "drug": "Amiodarone",
                                        "interacting_drug": "Warfarin",
                                        "description": "Amiodarone may enhance the anticoagulant effects of Warfarin.",
                                        "extended_description": "This combination can increase the risk of bleeding, requiring careful monitoring."
                                      },
                                      {
                                        "drug": "Buspirone",
                                        "interacting_drug": "MAOIs",
                                        "description": "MAOIs may increase the effects of Buspirone.",
                                        "extended_description": "This combination can lead to increased risk of serotonin syndrome."
                                      },
                                      {
                                        "drug": "Spironolactone",
                                        "interacting_drug": "ACE Inhibitors",
                                        "description": "ACE inhibitors may increase the risk of hyperkalemia when taken with Spironolactone.",
                                        "extended_description": "The combination can lead to elevated potassium levels."
                                      },
                                      {
                                        "drug": "Escitalopram",
                                        "interacting_drug": "CYP2C19 Inhibitors",
                                        "description": "CYP2C19 inhibitors may increase the levels of Escitalopram.",
                                        "extended_description": "This combination can lead to increased sedation and side effects."
                                      },
                                      {
                                        "drug": "Citalopram",
                                        "interacting_drug": "MAOIs",
                                        "description": "MAOIs may increase the effects of Citalopram.",
                                        "extended_description": "The combination can lead to increased risk of serotonin syndrome."
                                      },
                                      {
                                        "drug": "Furosemide",
                                        "interacting_drug": "Aminoglycosides",
                                        "description": "Aminoglycosides may enhance the ototoxic effects of Furosemide.",
                                        "extended_description": "This combination can lead to increased risk of hearing loss."
                                      },
                                      {
                                        "drug": "Acarbose",
                                        "interacting_drug": "Insulin",
                                        "description": "Insulin may enhance the effects of Acarbose.",
                                        "extended_description": "The combination can increase the risk of hypoglycemia."
                                      },
                                      {
                                        "drug": "Colchicine",
                                        "interacting_drug": "Statins",
                                        "description": "Colchicine may enhance the effects of Statins.",
                                        "extended_description": "The combination can lead to increased risk of muscle-related side effects."
                                      },
                                      {
                                        "drug": "Doxazosin",
                                        "interacting_drug": "Beta-Blockers",
                                        "description": "Beta-Blockers may enhance the effects of Doxazosin.",
                                        "extended_description": "This combination can lead to increased hypotension."
                                      },
                                      {
                                        "drug": "Meloxicam",
                                        "interacting_drug": "Lithium",
                                        "description": "Lithium may increase the levels of Meloxicam.",
                                        "extended_description": "This combination can lead to Lithium toxicity."
                                      },
                                      {
                                        "drug": "Zolpidem",
                                        "interacting_drug": "CNS Depressants",
                                        "description": "CNS depressants may enhance the sedative effects of Zolpidem.",
                                        "extended_description": "The combination can increase the risk of respiratory depression."
                                      },
                                      {
                                        "drug": "Venlafaxine",
                                        "interacting_drug": "MAOIs",
                                        "description": "MAOIs may increase the effects of Venlafaxine.",
                                        "extended_description": "The combination can lead to increased risk of serotonin syndrome."
                                      },
                                      {
                                        "drug": "Clonidine",
                                        "interacting_drug": "Beta-Blockers",
                                        "description": "Beta-Blockers may enhance the effects of Clonidine.",
                                        "extended_description": "This combination can lead to increased bradycardia."
                                      },
                                      {
                                        "drug": "Propranolol",
                                        "interacting_drug": "CYP2D6 Inhibitors",
                                        "description": "CYP2D6 inhibitors may increase the levels of Propranolol.",
                                        "extended_description": "The combination can lead to increased bradycardia and hypotension."
                                      },
                                      {
                                        "drug": "Methylphenidate",
                                        "interacting_drug": "MAOIs",
                                        "description": "MAOIs may increase the effects of Methylphenidate.",
                                        "extended_description": "This combination can lead to hypertensive crisis."
                                      },
                                      {
                                        "drug": "Tizanidine",
                                        "interacting_drug": "CNS Depressants",
                                        "description": "CNS depressants may enhance the sedative effects of Tizanidine.",
                                        "extended_description": "The combination can increase the risk of respiratory depression."
                                      },
                                      {
                                        "drug": "Sodium Oxybate",
                                        "interacting_drug": "CNS Depressants",
                                        "description": "CNS depressants may enhance the sedative effects of Sodium Oxybate.",
                                        "extended_description": "The combination can increase the risk of respiratory depression."
                                      },
                                      {
                                        "drug": "Divalproex Sodium",
                                        "interacting_drug": "Aspirin",
                                        "description": "Aspirin may increase the risk of bleeding when taken with Divalproex Sodium.",
                                        "extended_description": "The combination can lead to serious bleeding complications."
                                      },
                                      {
                                        "drug": "Chlordiazepoxide",
                                        "interacting_drug": "CNS Depressants",
                                        "description": "CNS depressants may enhance the sedative effects of Chlordiazepoxide.",
                                        "extended_description": "The combination can increase the risk of respiratory depression."
                                      },
                                      {
                                        "drug": "Rifampin",
                                        "interacting_drug": "Warfarin",
                                        "description": "Rifampin may reduce the anticoagulant effects of Warfarin.",
                                        "extended_description": "This combination can lead to increased risk of thrombosis."
                                      },
                                      {
                                        "drug": "Terazosin",
                                        "interacting_drug": "Beta-Blockers",
                                        "description": "Beta-Blockers may enhance the effects of Terazosin.",
                                        "extended_description": "The combination can lead to increased hypotension."
                                      },
                                      {
                                        "drug": "Isosorbide Mononitrate",
                                        "interacting_drug": "Sildenafil",
                                        "description": "Sildenafil may enhance the hypotensive effects of Isosorbide Mononitrate.",
                                        "extended_description": "The combination can lead to significant drops in blood pressure."
                                      },
                                      {
                                        "drug": "Bupropion",
                                        "interacting_drug": "MAOIs",
                                        "description": "MAOIs may increase the risk of hypertensive crisis when taken with Bupropion.",
                                        "extended_description": "This combination can lead to severe hypertension."
                                      },
                                      {
                                        "drug": "Methotrexate",
                                        "interacting_drug": "NSAIDs",
                                        "description": "NSAIDs may increase the risk of methotrexate toxicity.",
                                        "extended_description": "The combination can lead to increased risk of adverse effects."
                                      },
                                      {
                                        "drug": "Ciprofloxacin",
                                        "interacting_drug": "Theophylline",
                                        "description": "Ciprofloxacin may increase the levels of Theophylline.",
                                        "extended_description": "This combination can lead to toxicity and potential adverse effects."
                                      },
                                      {
                                        "drug": "Fentanyl",
                                        "interacting_drug": "CNS Depressants",
                                        "description": "CNS depressants may enhance the effects of Fentanyl.",
                                        "extended_description": "The combination can increase the risk of respiratory depression."
                                      },
                                      {
                                        "drug": "Dexamethasone",
                                        "interacting_drug": "Aspirin",
                                        "description": "Aspirin may increase the risk of gastrointestinal bleeding when taken with Dexamethasone.",
                                        "extended_description": "This combination can lead to serious bleeding complications."
                                      },
                                      {
                                        "drug": "Carbamazepine",
                                        "interacting_drug": "Oral Contraceptives",
                                        "description": "Carbamazepine may reduce the effectiveness of oral contraceptives.",
                                        "extended_description": "This combination can lead to unintended pregnancy."
                                      },
                                      {
                                        "drug": "Probenecid",
                                        "interacting_drug": "Penicillins",
                                        "description": "Probenecid may enhance the effects of Penicillins.",
                                        "extended_description": "This combination can lead to increased risk of side effects."
                                      },
                                      {
                                        "drug": "Desipramine",
                                        "interacting_drug": "CYP2D6 Inhibitors",
                                        "description": "CYP2D6 inhibitors may increase the levels of Desipramine.",
                                        "extended_description": "The combination can lead to increased sedation and side effects."
                                      },
                                      {
                                        "drug": "Asenapine",
                                        "interacting_drug": "CNS Depressants",
                                        "description": "CNS depressants may enhance the effects of Asenapine.",
                                        "extended_description": "This combination can increase the risk of respiratory depression."
                                      },
                                      {
                                        "drug": "Sitagliptin",
                                        "interacting_drug": "Digoxin",
                                        "description": "Digoxin levels may increase when taken with Sitagliptin.",
                                        "extended_description": "This combination can lead to increased risk of Digoxin toxicity."
                                      },
                                      {
                                        "drug": "Quetiapine",
                                        "interacting_drug": "CNS Depressants",
                                        "description": "CNS depressants may enhance the sedative effects of Quetiapine.",
                                        "extended_description": "This combination can increase the risk of respiratory depression."
                                      },
                                      {
                                        "drug": "Amitriptyline",
                                        "interacting_drug": "CYP2D6 Inhibitors",
                                        "description": "CYP2D6 inhibitors may increase the levels of Amitriptyline.",
                                        "extended_description": "The combination can lead to increased sedation and side effects."
                                      },
                                      {
                                        "drug": "Lisinopril",
                                        "interacting_drug": "Potassium-Sparing Diuretics",
                                        "description": "Potassium-sparing diuretics may increase the risk of hyperkalemia when taken with Lisinopril.",
                                        "extended_description": "The combination can lead to elevated potassium levels."
                                      },
                                      {
                                        "drug": "Rosuvastatin",
                                        "interacting_drug": "Antacids",
                                        "description": "Antacids may reduce the absorption of Rosuvastatin.",
                                        "extended_description": "This combination can lead to suboptimal cholesterol-lowering effects."
                                      },
                                      {
                                        "drug": "Alendronate",
                                        "interacting_drug": "Calcium Supplements",
                                        "description": "Calcium supplements may interfere with the absorption of Alendronate.",
                                        "extended_description": "This combination can lead to suboptimal treatment effects."
                                      },
                                      {
                                        "drug": "Hydrocodone",
                                        "interacting_drug": "Benzodiazepines",
                                        "description": "Benzodiazepines may enhance the sedative effects of Hydrocodone.",
                                        "extended_description": "This combination can increase the risk of respiratory depression."
                                      },
                                      {
                                        "drug": "Dabigatran",
                                        "interacting_drug": "P-glycoprotein Inhibitors",
                                        "description": "P-glycoprotein inhibitors may increase the levels of Dabigatran.",
                                        "extended_description": "The combination can increase the risk of bleeding."
                                      },
                                      {
                                        "drug": "Dronedarone",
                                        "interacting_drug": "Digoxin",
                                        "description": "Dronedarone may increase the levels of Digoxin.",
                                        "extended_description": "This combination can lead to Digoxin toxicity."
                                      },
                                      {
                                        "drug": "Etoricoxib",
                                        "interacting_drug": "Warfarin",
                                        "description": "Etoricoxib may enhance the anticoagulant effects of Warfarin.",
                                        "extended_description": "This combination can increase the risk of bleeding, requiring careful monitoring."
                                      },
                                      {
                                        "drug": "Fenofibrate",
                                        "interacting_drug": "Statins",
                                        "description": "Statins may increase the risk of muscle-related side effects when taken with Fenofibrate.",
                                        "extended_description": "The combination can lead to increased risk of rhabdomyolysis."
                                      },
                                      {
                                        "drug": "Azithromycin",
                                        "interacting_drug": "Digoxin",
                                        "description": "Azithromycin may increase the levels of Digoxin.",
                                        "extended_description": "This combination can lead to Digoxin toxicity."
                                      },
                                      {
                                        "drug": "Diltiazem",
                                        "interacting_drug": "Grapefruit Juice",
                                        "description": "Grapefruit juice may enhance the effects of Diltiazem.",
                                        "extended_description": "The combination can lead to increased risk of hypotension."
                                      },
                                      {
                                        "drug": "Benzodiazepines",
                                        "interacting_drug": "Alcohol",
                                        "description": "Alcohol may enhance the sedative effects of Benzodiazepines.",
                                        "extended_description": "This combination can increase the risk of respiratory depression."
                                      },
                                      {
                                        "drug": "Tramadol",
                                        "interacting_drug": "CNS Depressants",
                                        "description": "CNS depressants may enhance the effects of Tramadol.",
                                        "extended_description": "This combination can increase the risk of respiratory depression."
                                      },
                                      {
                                        "drug": "Dronabinol",
                                        "interacting_drug": "CNS Depressants",
                                        "description": "CNS depressants may enhance the effects of Dronabinol.",
                                        "extended_description": "This combination can increase the risk of respiratory depression."
                                      },
                                      {
                                        "drug": "Buspirone",
                                        "interacting_drug": "CYP3A4 Inhibitors",
                                        "description": "CYP3A4 inhibitors may increase the effects of Buspirone.",
                                        "extended_description": "This combination can lead to increased risk of serotonin syndrome."
                                      },
                                      {
                                        "drug": "Ciprofloxacin",
                                        "interacting_drug": "Warfarin",
                                        "description": "Ciprofloxacin may enhance the anticoagulant effects of Warfarin.",
                                        "extended_description": "This combination can increase the risk of bleeding, requiring careful monitoring."
                                      },
                                      {
                                        "drug": "Alprazolam",
                                        "interacting_drug": "CNS Depressants",
                                        "description": "CNS depressants may enhance the sedative effects of Alprazolam.",
                                        "extended_description": "This combination can increase the risk of respiratory depression."
                                      },
                                      {
                                        "drug": "Olanzapine",
                                        "interacting_drug": "CNS Depressants",
                                        "description": "CNS depressants may enhance the effects of Olanzapine.",
                                        "extended_description": "This combination can increase the risk of respiratory depression."
                                      },
                                      {
                                        "drug": "Sertraline",
                                        "interacting_drug": "MAOIs",
                                        "description": "MAOIs may increase the risk of serotonin syndrome when taken with Sertraline.",
                                        "extended_description": "This combination can lead to severe side effects."
                                      },
                                      {
                                        "drug": "Clonazepam",
                                        "interacting_drug": "CNS Depressants",
                                        "description": "CNS depressants may enhance the sedative effects of Clonazepam.",
                                        "extended_description": "This combination can increase the risk of respiratory depression."
                                      },
                                      {
                                        "drug": "Topiramate",
                                        "interacting_drug": "Alcohol",
                                        "description": "Alcohol may enhance the effects of Topiramate.",
                                        "extended_description": "This combination can increase the risk of side effects."
                                      },
                                      {
                                        "drug": "Risperidone",
                                        "interacting_drug": "CNS Depressants",
                                        "description": "CNS depressants may enhance the sedative effects of Risperidone.",
                                        "extended_description": "This combination can increase the risk of respiratory depression."
                                      },
                                      {
                                        "drug": "Dexamethasone",
                                        "interacting_drug": "NSAIDs",
                                        "description": "NSAIDs may increase the risk of gastrointestinal bleeding when taken with Dexamethasone.",
                                        "extended_description": "This combination can lead to serious bleeding complications."
                                      },
                                      {
                                        "drug": "Clopidogrel",
                                        "interacting_drug": "Proton Pump Inhibitors",
                                        "description": "Proton Pump Inhibitors may reduce the effectiveness of Clopidogrel.",
                                        "extended_description": "This combination can lead to an increased risk of cardiovascular events."
                                      },
                                      {
                                        "drug": "Gabapentin",
                                        "interacting_drug": "CNS Depressants",
                                        "description": "CNS depressants may enhance the sedative effects of Gabapentin.",
                                        "extended_description": "This combination can increase the risk of respiratory depression."
                                      },
                                      {
                                        "drug": "Meloxicam",
                                        "interacting_drug": "Aspirin",
                                        "description": "Aspirin may reduce the effectiveness of Meloxicam.",
                                        "extended_description": "This combination can lead to increased pain and inflammation."
                                      },
                                      {
                                        "drug": "Dopamine Agonists",
                                        "interacting_drug": "Antipsychotics",
                                        "description": "Antipsychotics may antagonize the effects of Dopamine Agonists.",
                                        "extended_description": "This combination can lead to reduced effectiveness of treatment."
                                      },
                                      {
                                        "drug": "Rivaroxaban",
                                        "interacting_drug": "CYP3A4 Inhibitors",
                                        "description": "CYP3A4 inhibitors may increase the levels of Rivaroxaban.",
                                        "extended_description": "This combination can increase the risk of bleeding."
                                      },
                                      {
                                        "drug": "Venlafaxine",
                                        "interacting_drug": "MAOIs",
                                        "description": "MAOIs may increase the risk of serotonin syndrome when taken with Venlafaxine.",
                                        "extended_description": "This combination can lead to severe side effects."
                                      },
                                      {
                                        "drug": "Amlodipine",
                                        "interacting_drug": "Simvastatin",
                                        "description": "Simvastatin may increase the risk of myopathy when taken with Amlodipine.",
                                        "extended_description": "This combination can lead to muscle-related side effects."
                                      },
                                      {
                                        "drug": "Metoprolol",
                                        "interacting_drug": "CYP2D6 Inhibitors",
                                        "description": "CYP2D6 inhibitors may increase the levels of Metoprolol.",
                                        "extended_description": "This combination can lead to increased hypotension."
                                      },
                                      {
                                        "drug": "Paroxetine",
                                        "interacting_drug": "MAOIs",
                                        "description": "MAOIs may increase the risk of serotonin syndrome when taken with Paroxetine.",
                                        "extended_description": "This combination can lead to severe side effects."
                                      },
                                      {
                                        "drug": "Duloxetine",
                                        "interacting_drug": "MAOIs",
                                        "description": "MAOIs may increase the risk of serotonin syndrome when taken with Duloxetine.",
                                        "extended_description": "This combination can lead to severe side effects."
                                      },
                                      {
                                        "drug": "Fluoxetine",
                                        "interacting_drug": "MAOIs",
                                        "description": "MAOIs may increase the risk of serotonin syndrome when taken with Fluoxetine.",
                                        "extended_description": "This combination can lead to severe side effects."
                                      },
                                      {
                                        "drug": "Pregabalin",
                                        "interacting_drug": "CNS Depressants",
                                        "description": "CNS depressants may enhance the sedative effects of Pregabalin.",
                                        "extended_description": "This combination can increase the risk of respiratory depression."
                                      },
                                      {
                                        "drug": "Acarbose",
                                        "interacting_drug": "Digoxin",
                                        "description": "Acarbose may reduce the absorption of Digoxin.",
                                        "extended_description": "This combination can lead to reduced effectiveness of Digoxin."
                                      },
                                      {
                                        "drug": "Codeine",
                                        "interacting_drug": "CNS Depressants",
                                        "description": "CNS depressants may enhance the effects of Codeine.",
                                        "extended_description": "This combination can increase the risk of respiratory depression."
                                      },
                                      {
                                        "drug": "Bupropion",
                                        "interacting_drug": "Nicotine Replacement Therapy",
                                        "description": "Nicotine replacement therapy may increase the risk of side effects when taken with Bupropion.",
                                        "extended_description": "This combination can lead to increased risk of seizures."
                                      },
                                      {
                                        "drug": "Escitalopram",
                                        "interacting_drug": "MAOIs",
                                        "description": "MAOIs may increase the risk of serotonin syndrome when taken with Escitalopram.",
                                        "extended_description": "This combination can lead to severe side effects."
                                      },
                                      {
                                        "drug": "Citalopram",
                                        "interacting_drug": "MAOIs",
                                        "description": "MAOIs may increase the risk of serotonin syndrome when taken with Citalopram.",
                                        "extended_description": "This combination can lead to severe side effects."
                                      },
                                      {
                                        "drug": "Clonidine",
                                        "interacting_drug": "CNS Depressants",
                                        "description": "CNS depressants may enhance the effects of Clonidine.",
                                        "extended_description": "This combination can increase the risk of respiratory depression."
                                      },
                                      {
                                        "drug": "Mirtazapine",
                                        "interacting_drug": "CNS Depressants",
                                        "description": "CNS depressants may enhance the sedative effects of Mirtazapine.",
                                        "extended_description": "This combination can increase the risk of respiratory depression."
                                      },
                                      {
                                        "drug": "Fluconazole",
                                        "interacting_drug": "Warfarin",
                                        "description": "Fluconazole may enhance the anticoagulant effects of Warfarin.",
                                        "extended_description": "This combination can increase the risk of bleeding, requiring careful monitoring."
                                      },
                                      {
                                        "drug": "Furosemide",
                                        "interacting_drug": "NSAIDs",
                                        "description": "NSAIDs may reduce the effectiveness of Furosemide.",
                                        "extended_description": "This combination can lead to fluid retention and increased blood pressure."
                                      },
                                      {
                                        "drug": "Azathioprine",
                                        "interacting_drug": "Allopurinol",
                                        "description": "Allopurinol may increase the risk of Azathioprine toxicity.",
                                        "extended_description": "This combination can lead to increased adverse effects."
                                      },
                                      {
                                        "drug": "Glyburide",
                                        "interacting_drug": "Beta-Blockers",
                                        "description": "Beta-blockers may mask the symptoms of hypoglycemia when taken with Glyburide.",
                                        "extended_description": "This combination can lead to unawareness of low blood sugar."
                                      },
                                      {
                                        "drug": "Benzodiazepines",
                                        "interacting_drug": "Opioids",
                                        "description": "Opioids may enhance the sedative effects of Benzodiazepines.",
                                        "extended_description": "This combination can increase the risk of respiratory depression."
                                      },
                                      {
                                        "drug": "Buspirone",
                                        "interacting_drug": "CNS Depressants",
                                        "description": "CNS depressants may enhance the sedative effects of Buspirone.",
                                        "extended_description": "This combination can increase the risk of respiratory depression."
                                      },
                                      {
                                        "drug": "Lamotrigine",
                                        "interacting_drug": "Oral Contraceptives",
                                        "description": "Oral contraceptives may reduce the effectiveness of Lamotrigine.",
                                        "extended_description": "This combination can lead to increased seizure frequency."
                                      },
                                      {
                                        "drug": "Quetiapine",
                                        "interacting_drug": "CNS Depressants",
                                        "description": "CNS depressants may enhance the sedative effects of Quetiapine.",
                                        "extended_description": "This combination can increase the risk of respiratory depression."
                                      },
                                      {
                                        "drug": "Ritonavir",
                                        "interacting_drug": "CYP3A4 Substrates",
                                        "description": "CYP3A4 substrates may have increased levels when taken with Ritonavir.",
                                        "extended_description": "This combination can lead to increased side effects."
                                      },
                                      {
                                        "drug": "Carbamazepine",
                                        "interacting_drug": "Oral Contraceptives",
                                        "description": "Oral contraceptives may reduce the effectiveness of Carbamazepine.",
                                        "extended_description": "This combination can lead to unplanned pregnancies."
                                      },
                                      {
                                        "drug": "Sildenafil",
                                        "interacting_drug": "Nitrates",
                                        "description": "Nitrates may enhance the hypotensive effects of Sildenafil.",
                                        "extended_description": "This combination can increase the risk of severe hypotension."
                                      },
                                      {
                                        "drug": "Lithium",
                                        "interacting_drug": "NSAIDs",
                                        "description": "NSAIDs may increase the levels of Lithium.",
                                        "extended_description": "This combination can lead to Lithium toxicity."
                                      },
                                      {
                                        "drug": "Clobazam",
                                        "interacting_drug": "CNS Depressants",
                                        "description": "CNS depressants may enhance the sedative effects of Clobazam.",
                                        "extended_description": "This combination can increase the risk of respiratory depression."
                                      },
                                      {
                                        "drug": "Paliperidone",
                                        "interacting_drug": "CNS Depressants",
                                        "description": "CNS depressants may enhance the sedative effects of Paliperidone.",
                                        "extended_description": "This combination can increase the risk of respiratory depression."
                                      },
                                      {
                                        "drug": "Amiodarone",
                                        "interacting_drug": "Warfarin",
                                        "description": "Warfarin may enhance the anticoagulant effects of Amiodarone.",
                                        "extended_description": "This combination can increase the risk of bleeding."
                                      },
                                      {
                                        "drug": "Amitriptyline",
                                        "interacting_drug": "MAOIs",
                                        "description": "MAOIs may increase the risk of serotonin syndrome when taken with Amitriptyline.",
                                        "extended_description": "This combination can lead to severe side effects."
                                      },
                                      {
                                        "drug": "Oxycodone",
                                        "interacting_drug": "CNS Depressants",
                                        "description": "CNS depressants may enhance the effects of Oxycodone.",
                                        "extended_description": "This combination can increase the risk of respiratory depression."
                                      },
                                      {
                                        "drug": "Methotrexate",
                                        "interacting_drug": "NSAIDs",
                                        "description": "NSAIDs may increase the risk of Methotrexate toxicity.",
                                        "extended_description": "This combination can lead to serious adverse effects."
                                      },
                                      {
                                        "drug": "Bupropion",
                                        "interacting_drug": "CYP2D6 Inhibitors",
                                        "description": "CYP2D6 inhibitors may increase the levels of Bupropion.",
                                        "extended_description": "This combination can lead to increased risk of seizures."
                                      },
                                      {
                                        "drug": "Tramadol",
                                        "interacting_drug": "CNS Depressants",
                                        "description": "CNS depressants may enhance the effects of Tramadol.",
                                        "extended_description": "This combination can increase the risk of respiratory depression."
                                      },
                                      {
                                        "drug": "Digoxin",
                                        "interacting_drug": "CYP3A4 Inhibitors",
                                        "description": "CYP3A4 inhibitors may increase the levels of Digoxin.",
                                        "extended_description": "This combination can increase the risk of toxicity."
                                      },
                                      {
                                        "drug": "Naproxen",
                                        "interacting_drug": "Warfarin",
                                        "description": "Warfarin may enhance the anticoagulant effects of Naproxen.",
                                        "extended_description": "This combination can increase the risk of bleeding."
                                      },
                                      {
                                        "drug": "Fentanyl",
                                        "interacting_drug": "CNS Depressants",
                                        "description": "CNS depressants may enhance the effects of Fentanyl.",
                                        "extended_description": "This combination can increase the risk of respiratory depression."
                                      },
                                      {
                                        "drug": "Oxycodone",
                                        "interacting_drug": "Benzodiazepines",
                                        "description": "Benzodiazepines may enhance the effects of Oxycodone.",
                                        "extended_description": "This combination can increase the risk of respiratory depression."
                                      },
                                      {
                                        "drug": "Sodium Bicarbonate",
                                        "interacting_drug": "Digoxin",
                                        "description": "Sodium Bicarbonate may reduce the effectiveness of Digoxin.",
                                        "extended_description": "This combination can lead to reduced therapeutic effects."
                                      },
                                      {
                                        "drug": "Rifampin",
                                        "interacting_drug": "Oral Contraceptives",
                                        "description": "Oral contraceptives may have reduced effectiveness when taken with Rifampin.",
                                        "extended_description": "This combination can lead to unplanned pregnancies."
                                      },
                                      {
                                        "drug": "Hydrochlorothiazide",
                                        "interacting_drug": "Lithium",
                                        "description": "Lithium levels may increase when taken with Hydrochlorothiazide.",
                                        "extended_description": "This combination can lead to Lithium toxicity."
                                      },
                                      {
                                        "drug": "Methadone",
                                        "interacting_drug": "CNS Depressants",
                                        "description": "CNS depressants may enhance the effects of Methadone.",
                                        "extended_description": "This combination can increase the risk of respiratory depression."
                                      },
                                      {
                                        "drug": "Isosorbide Mononitrate",
                                        "interacting_drug": "Sildenafil",
                                        "description": "Sildenafil may enhance the hypotensive effects of Isosorbide Mononitrate.",
                                        "extended_description": "This combination can increase the risk of severe hypotension."
                                      },
                                      {
                                        "drug": "Verapamil",
                                        "interacting_drug": "Digoxin",
                                        "description": "Digoxin levels may increase when taken with Verapamil.",
                                        "extended_description": "This combination can lead to Digoxin toxicity."
                                      },
                                      {
                                        "drug": "Esomeprazole",
                                        "interacting_drug": "Clopidogrel",
                                        "description": "Clopidogrel may have reduced effectiveness when taken with Esomeprazole.",
                                        "extended_description": "This combination can lead to increased cardiovascular events."
                                      },
                                      {
                                        "drug": "Citalopram",
                                        "interacting_drug": "CNS Depressants",
                                        "description": "CNS depressants may enhance the sedative effects of Citalopram.",
                                        "extended_description": "This combination can increase the risk of respiratory depression."
                                      },
                                      {
                                        "drug": "Olaparib",
                                        "interacting_drug": "CYP3A4 Inhibitors",
                                        "description": "CYP3A4 inhibitors may increase the levels of Olaparib.",
                                        "extended_description": "This combination can increase the risk of side effects."
                                      },
                                      {
                                        "drug": "Diclofenac",
                                        "interacting_drug": "Warfarin",
                                        "description": "Warfarin may enhance the anticoagulant effects of Diclofenac.",
                                        "extended_description": "This combination can increase the risk of bleeding."
                                      },
                                      {
                                        "drug": "Olmesartan",
                                        "interacting_drug": "NSAIDs",
                                        "description": "NSAIDs may reduce the effectiveness of Olmesartan.",
                                        "extended_description": "This combination can lead to increased blood pressure."
                                      },
                                      {
                                        "drug": "Bupropion",
                                        "interacting_drug": "Amitriptyline",
                                        "description": "Amitriptyline may increase the risk of seizures when taken with Bupropion.",
                                        "extended_description": "This combination can lead to increased risk of seizures."
                                      },
                                      {
                                        "drug": "Clozapine",
                                        "interacting_drug": "CNS Depressants",
                                        "description": "CNS depressants may enhance the sedative effects of Clozapine.",
                                        "extended_description": "This combination can increase the risk of respiratory depression."
                                      },
                                      {
                                        "drug": "Aspirin",
                                        "interacting_drug": "Warfarin",
                                        "description": "Warfarin may enhance the anticoagulant effects of Aspirin.",
                                        "extended_description": "This combination can increase the risk of bleeding."
                                      },
                                      {
                                        "drug": "Chlordiazepoxide",
                                        "interacting_drug": "CNS Depressants",
                                        "description": "CNS depressants may enhance the sedative effects of Chlordiazepoxide.",
                                        "extended_description": "This combination can increase the risk of respiratory depression."
                                    }
                                ];
              
              
      
  